Micron Technology (MU) 10-K7 Oct 222022 FY Annual reportFinancial data

Company Profile

Cover Page

Cover Page - USD ($) $ in Billions	12 Months Ended
Cover Page - USD ($) $ in Billions	Sep. 01, 2022	Sep. 30, 2022	Mar. 03, 2022
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Sep. 01, 2022
Document Transition Report	false
Entity File Number	1-10658
Entity Registrant Name	Micron Technology, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	75-1618004
Entity Address, Address Line One	8000 S. Federal Way
Entity Address, City or Town	Boise
Entity Address, State or Province	ID
Entity Address, Postal Zip Code	83716
City Area Code	208
Local Phone Number	368-4000
Title of 12(b) Security	Common Stock, par value $0.10 per share
Trading Symbol	MU
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Entity Shell Company	false
Entity Public Float			$ 83.9
Entity Common Stock, Shares Outstanding		1,087,168,584
Documents Incorporated by Reference	DOCUMENTS INCORPORATED BY REFERENCE Portions of the Proxy Statement for the registrant’s Fiscal 2022 Annual Meeting of Shareholders to be held on January 12, 2023 are incorporated by reference into Part II and Part III of this Annual Report on Form 10-K.
Entity Central Index Key	0000723125
Current Fiscal Year End Date	--09-01
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY
Amendment Flag	false

Audit Information

Audit Information	12 Months Ended
Audit Information	Sep. 01, 2022
Audit Information [Abstract]
Auditor Name	PricewaterhouseCoopers LLP
Auditor Location	San Jose, California
Auditor Firm ID	238

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Sep. 01, 2022	Sep. 02, 2021	Sep. 03, 2020
Income Statement [Abstract]
Revenue	$ 30,758	$ 27,705	$ 21,435
Cost of goods sold	16,860	17,282	14,883
Gross margin	13,898	10,423	6,552
Research and development	3,116	2,663	2,600
Selling, general, and administrative	1,066	894	881
Restructure and asset impairments	48	488	60
Other operating (income) expense, net	(34)	95	8
Operating income	9,702	6,283	3,003
Interest income	96	37	114
Interest expense	(189)	(183)	(194)
Other non-operating income (expense), net	(38)	81	60
Income (loss) before income taxes, net income (loss) attributable to noncontrolling interests, and equity in net income (loss) of equity method investees	9,571	6,218	2,983
Income tax (provision) benefit	(888)	(394)	(280)
Equity in net income (loss) of equity method investees	4	37	7
Net income	8,687	5,861	2,710
Net income attributable to noncontrolling interests	0	0	(23)
Net income attributable to Micron	$ 8,687	$ 5,861	$ 2,687
Earnings per share
Basic (in dollars per share)	$ 7.81	$ 5.23	$ 2.42
Diluted (in dollars per share)	$ 7.75	$ 5.14	$ 2.37
Number of shares used in per share calculations
Basic (in shares)	1,112	1,120	1,110
Diluted (in shares)	1,122	1,141	1,131

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Millions	12 Months Ended
	Sep. 01, 2022	Sep. 02, 2021	Sep. 03, 2020
Statement of Comprehensive Income [Abstract]
Net income	$ 8,687	$ 5,861	$ 2,710
Other comprehensive income (loss), net of tax
Gains (losses) on derivative instruments	(516)	(67)	46
Gains (losses) on investments	(48)	(7)	1
Foreign currency translation adjustments	(1)	2	0
Pension liability adjustments	3	3	15
Other comprehensive income (loss)	(562)	(69)	62
Total comprehensive income	8,125	5,792	2,772
Comprehensive income attributable to noncontrolling interests	0	0	(23)
Comprehensive income attributable to Micron	$ 8,125	$ 5,792	$ 2,749

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions		Sep. 01, 2022	Sep. 02, 2021
Assets
Cash and equivalents		$ 8,262	$ 7,763
Short-term investments		1,069	870
Receivables		5,130	5,311
Inventories		6,663	4,487
Assets held for sale		13	974
Other current assets		644	502
Total current assets		21,781	19,907
Long-term marketable investments	[1]	1,647	1,765
Property, plant, and equipment		38,549	33,213
Operating lease right-of-use assets		678	551
Intangible assets		421	349
Deferred tax assets		702	782
Goodwill		1,228	1,228
Other noncurrent assets		1,277	1,054
Total assets		66,283	58,849
Liabilities and equity
Accounts payable and accrued expenses		6,090	5,325
Current debt		103	155
Other current liabilities		1,346	944
Total current liabilities		7,539	6,424
Long-term debt		6,803	6,621
Noncurrent operating lease liabilities		610	504
Noncurrent unearned government incentives		589	808
Other noncurrent liabilities		835	559
Total liabilities		16,376	14,916
Commitments and contingencies
Shareholders’ equity
Common stock, $0.10 par value, 3,000 shares authorized, 1,226 shares issued and 1,094 outstanding (1,216 shares issued and 1,119 outstanding as of September 2, 2021)		123	122
Additional capital		10,197	9,453
Retained earnings		47,274	39,051
Treasury stock, 132 shares held (97 shares as of September 2, 2021)		(7,127)	(4,695)
Accumulated other comprehensive income (loss)		(560)	2
Total equity		49,907	43,933
Total liabilities and equity		$ 66,283	$ 58,849

[1] The maturities of long-term marketable securities primarily range from one four years.

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares shares in Millions	Sep. 01, 2022	Sep. 02, 2021
Shareholders’ equity
Common Stock, par value (in dollars per share)	$ 0.10	$ 0.10
Common Stock, authorized shares (in shares)	3,000	3,000
Common Stock, issued (in shares)	1,226	1,216
Common Stock, outstanding (in shares)	1,094	1,119
Treasury Stock, held (in shares)	132	97

STATEMENT OF CHANGES IN EQUITY

STATEMENT OF CHANGES IN EQUITY - USD ($) shares in Millions, $ in Millions	Total	Common Stock	Additional Capital	Retained Earnings	Treasury Stock	Accumulated Other Comprehensive Income (Loss)	Total Micron Shareholders’ Equity	Noncontrolling Interests in Subsidiaries
Balance (in shares) at Aug. 29, 2019		1,182
Balance of equity (including noncontrolling interest) at Aug. 29, 2019	$ 36,770	$ 118	$ 8,214	$ 30,761	$ (3,221)	$ 9	$ 35,881	$ 889
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (including redeemable noncontrolling interest)	2,702			2,687			2,687	15
Net income	2,687
Other comprehensive income (loss), net	62					62	62
Stock issued under stock plans (in shares)		14
Stock issued under stock plans	225	$ 1	224				225
Stock-based compensation expense	328		328				328
Repurchase of stock - repurchase program	(176)				(176)		(176)
Repurchase of stock - withholdings on employee equity awards (in shares)		(2)
Repurchase of stock - withholdings on employee equity awards	(75)	$ 0	(11)	(64)			(75)
Settlement of capped calls	0		98		(98)		0
Acquisitions of noncontrolling interest	(784)		120				120	(904)
Cash settlement of convertible notes	(56)		(56)				(56)
Balance (in shares) at Sep. 03, 2020		1,194
Balance of equity (including noncontrolling interest) at Sep. 03, 2020	38,996	$ 119	8,917	33,384	(3,495)	71	$ 38,996	$ 0
Balance of total equity at Sep. 03, 2020	38,996	$ 119	8,917	33,384	(3,495)	71
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	5,861			5,861
Other comprehensive income (loss), net	(69)					(69)
Stock issued under stock plans (in shares)		13
Stock issued under stock plans	225	$ 2	223
Stock-based compensation expense	378		378
Repurchase of stock - repurchase program	(1,200)				(1,200)
Repurchase of stock - withholdings on employee equity awards (in shares)		(2)
Repurchase of stock - withholdings on employee equity awards	(94)	$ 0	(12)	(82)
Cash settlement of convertible notes	(52)		(52)
Stock issued for convertible notes (shares)		11
Stock issued for convertible notes	$ 0	$ 1	(1)
Cash dividends declared (per share)	$ 0.10
Dividends and dividend equivalents declared	$ (112)			(112)
Balance (in shares) at Sep. 02, 2021	1,216	1,216
Balance of total equity at Sep. 02, 2021	$ 43,933	$ 122	9,453	39,051	(4,695)	2
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	8,687			8,687
Other comprehensive income (loss), net	(562)					(562)
Stock issued under stock plans (in shares)		12
Stock issued under stock plans	245	$ 1	244
Stock-based compensation expense	514		514
Repurchase of stock - repurchase program	(2,432)				(2,432)
Repurchase of stock - withholdings on employee equity awards (in shares)		(2)
Repurchase of stock - withholdings on employee equity awards	$ (126)	$ 0	(14)	(112)
Cash dividends declared (per share)	$ 0.315
Dividends and dividend equivalents declared	$ (352)			(352)
Balance (in shares) at Sep. 01, 2022	1,226	1,226
Balance of total equity at Sep. 01, 2022	$ 49,907	$ 123	$ 10,197	$ 47,274	$ (7,127)	$ (560)

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Sep. 01, 2022	Sep. 02, 2021	Sep. 03, 2020
Cash flows from operating activities
Net income	$ 8,687	$ 5,861	$ 2,710
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation expense and amortization of intangible assets	7,116	6,214	5,650
Stock-based compensation	514	378	328
(Gain) loss on debt repurchases and conversions	83	1	(40)
Restructure and asset impairments	44	454	40
Change in operating assets and liabilities:
Receivables	190	(1,446)	(723)
Inventories	(2,179)	866	(435)
Accounts payable and accrued expenses	744	210	725
Other	(18)	(70)	51
Net cash provided by operating activities	15,181	12,468	8,306
Cash flows from investing activities
Expenditures for property, plant, and equipment	(12,067)	(10,030)	(8,223)
Purchases of available-for-sale securities	(1,770)	(3,163)	(1,857)
Proceeds from maturities of available-for-sale securities	1,321	1,250	814
Proceeds from sale of Lehi, Utah fab	888	0	0
Proceeds from sales of available-for-sale securities	294	856	1,458
Proceeds from government incentives	115	495	262
Other	(366)	3	(43)
Net cash provided by (used for) investing activities	(11,585)	(10,589)	(7,589)
Cash flows from financing activities
Repurchases of common stock - repurchase program	(2,432)	(1,200)	(176)
Repayments of debt	(2,032)	(1,520)	(4,366)
Payments of dividends to shareholders	(461)	0	0
Payments on equipment purchase contracts	(141)	(295)	(63)
Repurchases of common stock - withholdings on employee equity awards	(125)	(94)	(75)
Acquisition of noncontrolling interest in IMFT	0	0	(744)
Proceeds from issuance of debt	2,000	1,188	5,000
Other	211	140	107
Net cash provided by (used for) financing activities	(2,980)	(1,781)	(317)
Effect of changes in currency exchange rates on cash, cash equivalents, and restricted cash	(106)	41	11
Net increase (decrease) in cash, cash equivalents, and restricted cash	510	139	411
Cash, cash equivalents, and restricted cash at beginning of period	7,829	7,690	7,279
Cash, cash equivalents, and restricted cash at end of period	8,339	7,829	7,690
Supplemental disclosures
Income taxes paid, net	(493)	(361)	(167)
Interest paid, net of amounts capitalized	(154)	(171)	(165)
Capital Expenditures Incurred on Purchase Contracts Not Yet Paid	$ 157	$ 289	$ 171

Significant Accounting Policies

Significant Accounting Policies	12 Months Ended
Significant Accounting Policies	Sep. 01, 2022
Accounting Policies [Abstract]
Significant Accounting Policies	Significant Accounting Policies Basis of Presentation We are an industry leader in innovative memory and storage solutions transforming how the world uses information to enrich life for all . With a relentless focus on our customers, technology leadership, and manufacturing and operational excellence, Micron delivers a rich portfolio of high-performance DRAM, NAND, and NOR memory and storage products through our Micron® and Crucial® brands. Every day, the innovations that our people create fuel the data economy, enabling advances in artificial intelligence and 5G applications that unleash opportunities — from the data center to the intelligent edge and across the client and mobile user experience. The accompanying consolidated financial statements include the accounts of Micron Technology, Inc. and our consolidated subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America. Intercompany balances and transactions have been eliminated in consolidation. Certain reclassifications have been made to prior period amounts to conform to current period presentation. See “Inventories” below for changes to our significant accounting policies, and the “Inventories” note for additional information. Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Fiscal 2022 and 2021 each contained 52 weeks and fiscal 2020 contained 53 weeks. Our fourth quarter of fiscal 2020 contained 14 weeks and all other fiscal quarters in the years presented contained 13 weeks. All period references are to our fiscal periods unless otherwise indicated. Derivative and Hedging Instruments We use derivative instruments to manage our exposure to changes in currency exchange rates from (1) our monetary assets and liabilities denominated in currencies other than the U.S. dollar and (2) forecasted cash flows for certain capital expenditures and manufacturing costs. We also use derivative instruments to manage our exposure to changes in commodity prices for manufacturing supplies and to minimize certain exposures to changes in the fair value of fixed-rate debt that result from fluctuations in benchmark interest rates. Derivative instruments are measured at their fair values and recognized as either assets or liabilities. The accounting for changes in the fair value of derivative instruments is based on the intended use of the derivative and the resulting designation. For derivative instruments that are not designated for hedge accounting, gains or losses from changes in fair values are recognized in other non-operating income (expense). For derivative instruments designated as cash flow hedges, gains or losses are included as a component of accumulated other comprehensive income and reclassified into earnings in the same line items and in the same periods in which the underlying transactions affect earnings. For derivative instruments designated as cash flow hedges, time value is excluded from the assessment of effectiveness and the gains and losses attributable to time value are recognized in earnings. For derivative instruments designated as fair value hedges, changes in the fair values of the derivative instruments and the offsetting changes in the fair values of the underlying hedged items are both recognized in earnings. We enter into master netting arrangements with our counterparties to mitigate credit risk in derivative hedge transactions. These master netting arrangements allow us and our counterparties to net settle amounts owed to each other. Derivative assets and liabilities that can be net settled with each counterparty have been presented in our consolidated balance sheet on a net basis. Financial Instruments Cash equivalents include highly liquid short-term investments with original maturities to us of three months or less that are readily convertible to known amounts of cash. Other investments with remaining maturities of less than one year are included in short-term investments. Investments with remaining maturities greater than one year are included in long-term marketable investments. The carrying value of investment securities sold is determined using the specific identification method. Functional Currency The U.S. dollar is the functional currency for us and all of our consolidated subsidiaries. Goodwill We perform an annual impairment assessment for goodwill in our fourth quarter each year. Government Incentives We receive incentives from governmental entities related to expenses, assets, and other activities. Our government incentives may require that we meet or maintain specified spending levels and other operational metrics and may be subject to reimbursement if such conditions are not met or maintained. Government incentives are recorded in the financial statements in accordance with their purpose: as a reduction of expenses, a reduction of asset costs, or other income. Incentives related to specific operating activities are offset against the related expense in the period the expense is incurred. Incentives related to the acquisition or construction of fixed assets are recognized as a reduction in the carrying amounts of the related assets and reduce depreciation expense over the useful lives of the assets. Other incentives are recognized as other operating income. Government incentives received prior to being earned are recognized in current or noncurrent deferred income or restricted cash, whereas government incentives earned prior to being received are recognized in current or noncurrent receivables. Cash received from government incentives related to operating expenses is included as an operating activity in the statement of cash flows, whereas cash received from incentives related to the acquisition of property, plant, and equipment is included as an investing activity. Inventories Effective as of the beginning of the second quarter of 2021, we changed the method of inventory costing from average cost to FIFO. The difference between average cost and FIFO was not material to any previously reported financial statements. Therefore, we have recognized the cumulative effect of the change as a reduction of inventories and a charge to cost of goods sold of $133 million as of the beginning of the second quarter of 2021. Inventories are stated at the lower of cost or net realizable value, with cost being determined on a FIFO basis. Cost includes depreciation, labor, material, and overhead costs, including product and process technology costs. When net realizable value (which requires projecting future average selling prices, sales volumes, and costs to complete products in work in process inventories) is below cost, we record a charge to cost of goods sold to write down inventories to their estimated net realizable value in advance of when inventories are actually sold. We review the major characteristics of product type and markets in determining the unit of account for which we perform the lower of cost or net realizable value analysis and categorize all inventories (including DRAM, NAND, and other memory) as a single group. We remove amounts from inventory and charge such amounts to cost of goods sold on a FIFO basis. Leases We determine if an arrangement is a lease, or contains a lease, at the inception of the arrangement and evaluate whether the lease is an operating lease or a finance lease at the commencement date. We recognize right-of-use assets and lease liabilities for operating and finance leases with terms greater than 12 months. Right-of-use assets represent our right to use an asset for the lease term, while lease liabilities represent our obligation to make lease payments. We do not separate lease and non-lease components for real-estate and gas plant leases. Sublease income is included within lease expense. Product and Process Technology Costs incurred to (1) acquire product and process technology, (2) patent technology, and (3) maintain patent technology, are capitalized and amortized on a straight-line basis over periods ranging up to 12.5 years. We capitalize a portion of costs incurred to patent technology based on historical data of patents issued as a percent of patents we file. Product and process technology costs are amortized over the shorter of (1) the estimated useful life of the technology, (2) the patent term, or (3) the term of the technology agreement. Fully-amortized assets are removed from product and process technology and accumulated amortization. Product Warranty We generally provide a limited warranty that our products are in compliance with applicable specifications existing at the time of delivery. Under our standard terms and conditions of sale, liability for certain failures of product during a stated warranty period is usually limited to repair or replacement of defective items or return of, or a credit with respect to, amounts paid for such items. Under certain circumstances, we provide more extensive limited warranty coverage than that provided under our standard terms and conditions. Our warranty obligations are not material. Property, Plant, and Equipment Property, plant, and equipment is stated at cost and depreciated using the straight-line method over estimated useful lives of generally 10 to 30 years for buildings, 5 to 7 years for equipment, and 3 to 5 years for software. Assets held for sale are carried at the lower of estimated fair value or carrying value and are included in current assets. When property, plant, or equipment is retired or otherwise disposed, the net book value is removed and we recognize any gain or loss in results of operations. We capitalize interest on borrowings during the period of time we carry out the activities necessary to bring assets to the condition of their intended use and location. Capitalized interest becomes part of the cost of assets. Research and Development Costs related to the conceptual formulation and design of products and processes are charged to R&D expense as incurred. Development of a product is deemed complete when it is qualified through reviews and tests for performance and reliability. Subsequent to product qualification, product costs are included in cost of goods sold. Amounts from cost-sharing arrangements are reflected as a reduction of R&D expense. Revenue Recognition Revenue is primarily recognized at a point in time when control of the promised goods is transferred to our customers in an amount that reflects the consideration we expect to be entitled to in exchange for those goods. Contracts with our customers are generally short-term in duration at fixed, negotiated prices with payment generally due shortly after delivery. We estimate a liability for returns using the expected value method based on historical returns. In addition, we generally offer price protection to our distributors, which is a form of variable consideration that decreases the transaction price. We use the expected value method, based on historical price adjustments and current pricing trends, to estimate the amount of revenue recognized from sales to distributors. Differences between the estimated and actual amounts are recognized as adjustments to revenue. Stock-based Compensation Stock-based compensation is measured at the grant date, based on the fair value of the award, and recognized as expense under the straight-line attribution method over the requisite service period. We account for forfeitures as they occur. We issue new shares upon the exercise of stock options, conversion of share units, or issuance of shares under our ESPP. Treasury Stock Treasury stock is carried at cost. When we retire our treasury stock, any excess of the repurchase price paid over par value is allocated between additional capital and retained earnings. Use of Estimates The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires our management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, expenses, and related disclosures. Estimates and judgments are based on historical experience, forecasted events, and various other assumptions that we believe to be reasonable under the circumstances. Estimates and judgments may differ under different assumptions or conditions. We evaluate our estimates and judgments on an ongoing basis. Actual results could differ from estimates.

Lehi, Utah Fab and 3D XPoint

Lehi, Utah Fab and 3D XPoint	12 Months Ended
Lehi, Utah Fab and 3D XPoint	Sep. 01, 2022
Lehi, Utah Facility
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Lehi, Utah Fab and 3D XPoint	Lehi, Utah Fab and 3D XPoint In the second quarter of 2021, we updated our portfolio strategy to further strengthen our focus on memory and storage innovations for the data center market. In connection therewith, we determined that there was insufficient market validation to justify the ongoing investments required to commercialize 3D XPoint at scale. Accordingly, we ceased development of 3D XPoint technology and engaged in discussions with potential buyers for the sale of our facility located in Lehi, Utah that was dedicated to 3D XPoint production. As a result, we classified the property, plant, and equipment as held for sale as of the second quarter of 2021 and ceased depreciating the assets. On June 30, 2021, we announced a definitive agreement to sell our Lehi facility to TI and closed the sale on October 22, 2021. In the first quarter of 2022, we received $893 million from TI for the sale of the Lehi facility and disposed of $918 million of net assets, consisting primarily of property, plant, and equipment of $921 million; $55 million of other assets, consisting primarily of a receivable for reimbursement of property taxes, equipment spare parts, and raw materials; and $58 million of liabilities, consisting primarily of a finance lease obligation. As a result of the disposition of the Lehi facility and other related adjustments, we recognized a loss of $23 million included in restructure and asset impairments In 2021, we recognized a charge of $435 million included in restructure and asset impairments in connection with the definitive agreement with TI (and a tax benefit of $104 million included in income tax (provision) benefit) to write down the assets held for sale to the expected consideration, net of estimated selling costs. The impairment charge was based on Level 3 inputs including expected consideration and the composition of assets included in the sale, which were derived from the agreement with TI. We also recognized a charge of $49 million to cost of goods sold in 2021 to write down 3D XPoint inventory due to our decision to cease further development of this technology. Our 3D XPoint technology development and Lehi facility operations were primarily included in our CNBU segment results. As of September 2, 2021, the significant balances of assets held for sale in connection with our Lehi facility were as follows: As of September 2, Property, plant, and equipment $ 1,334 Other current assets 50 Impairment (435) Lehi assets held for sale $ 949 As of September 2, 2021, we also had a $50 million finance lease obligation included in the current portion of long-term debt and $11 million of other liabilities that were subsequently transferred with the sale. As of September 2, 2021, the carrying value of the Lehi assets held for sale approximated the expected cash consideration, net of estimated selling expenses.

Variable Interest Entities

Variable Interest Entities	12 Months Ended
Variable Interest Entities	Sep. 01, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Variable Interest Entities	Variable Interest Entities We have interests in entities that are variable interest entities (“VIEs”). If we are the primary beneficiary of a VIE, we are required to consolidate it. To determine if we are the primary beneficiary, we evaluate whether we have the power to direct the activities that most significantly impact the VIE’s economic performance and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the VIE. Our evaluation includes identification of significant activities and an assessment of our ability to direct those activities based on governance provisions and arrangements to provide or receive product and process technology, product supply, operations services, equity funding, financing, and other applicable agreements and circumstances. Our assessments of whether we are the primary beneficiary of our VIEs require significant assumptions and judgments. Through the first quarter of 2020, IMFT, which operated a facility in Lehi, Utah, was a VIE because all of its costs were passed to us and its other member, Intel, through product purchase agreements and because IMFT was dependent upon us or Intel for additional cash requirements. The primary activities of IMFT were driven by the constant introduction of product and process technology. Because we performed a significant majority of the technology development, we had the power to direct its key activities. We consolidated IMFT due to this power and our obligation to absorb losses and the right to receive benefits from IMFT that could have been potentially significant to it. In the first quarter of 2020, we paid $1.25 billion to acquire Intel’s noncontrolling interest in IMFT and settle IMFT’s debt obligations to Intel, at which time IMFT became a wholly-owned subsidiary. In connection therewith, we recognized a $160 million adjustment to equity for the difference between the $744 million of cash consideration allocated to Intel’s noncontrolling interest and its $904 million carrying value.

Cash and Investments

Cash and Investments	12 Months Ended
Cash and Investments	Sep. 01, 2022
Investments and Cash [Abstract]
Cash and Investments	Cash and Investments All of our marketable debt investments were classified as available-for-sale as of the dates noted below. Cash and equivalents and the fair values of our available-for-sale investments, which approximated amortized costs, were as follows: 2022 2021 As of Cash and Equivalents Short-term Investments Long-term Marketable Investments (1) Total Fair Value Cash and Equivalents Short-term Investments Long-term Marketable Investments (1) Total Fair Value Cash $ 6,055 $ — $ — $ 6,055 $ 5,796 $ — $ — $ 5,796 Level 1 (2) Money market funds 1,196 — — 1,196 38 — — 38 Level 2 (3) Certificates of deposits 976 50 — 1,026 1,907 69 — 1,976 Corporate bonds — 759 995 1,754 9 429 1,134 1,572 Asset-backed securities — 20 608 628 8 95 509 612 Government securities 2 155 44 201 1 190 122 313 Commercial paper 33 85 — 118 4 87 — 91 8,262 $ 1,069 $ 1,647 $ 10,978 7,763 $ 870 $ 1,765 $ 10,398 Restricted cash (4) 77 66 Cash, cash equivalents, and restricted cash $ 8,339 $ 7,829 (1) The maturities of long-term marketable securities primarily range from one four years. (2) The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets. (3) The fair value of Level 2 securities is measured using information obtained from pricing services, which obtain quoted market prices for similar instruments, non-binding market consensus prices that are corroborated by observable market data, or various other methodologies, to determine the appropriate value at the measurement date. We perform supplemental analysis to validate information obtained from these pricing services. No adjustments were made to the fair values indicated by such pricing information as of September 1, 2022 or September 2, 2021. (4) Restricted cash is included in other current assets and other noncurrent assets and primarily relates to certain government incentives received prior to being earned and for which restrictions lapse upon achieving certain performance conditions. Gross realized gains and losses from sales of available-for-sale securities were not significant for any period presented. Non-marketable Equity Investments In addition to the amounts included in the table above, we had $222 million and $153 million of non-marketable equity investments without a readily determinable fair value that were included in other noncurrent assets as of September 1, 2022 and September 2, 2021, respectively. We recognized net gains in other non-operating income on these non-marketable investments of $36 million and $70 million for 2022 and 2021, respectively. These gains primarily resulted from adjustments of these investments to the value indicated by transactions in the same or similar investments.

Receivables

Receivables	12 Months Ended
Receivables	Sep. 01, 2022
Receivables [Abstract]
Receivables	Receivables As of 2022 2021 Trade receivables $ 4,765 $ 4,920 Income and other taxes 251 264 Other 114 127 $ 5,130 $ 5,311

Inventories

Inventories	12 Months Ended
Inventories	Sep. 01, 2022
Inventory Disclosure [Abstract]
Inventories	Inventories As of 2022 2021 Finished goods $ 1,028 $ 513 Work in process 4,830 3,469 Raw materials and supplies 805 505 $ 6,663 $ 4,487 Effective as of the beginning of the second quarter of 2021, we changed our method of inventory costing from average cost to FIFO. This change in accounting principle is preferable because in an environment with continuously changing production costs FIFO more closely matches the actual cost of goods sold with the revenues from sales of those specific units, better represents the actual cost of inventories remaining on hand at any period-end, and improves comparability with our semiconductor industry peers. The change to FIFO was not material to any prior periods, nor was the cumulative effect of $133 million material to the second quarter of 2021. As such, prior periods were not retrospectively adjusted, and the cumulative effect was reported as an increase to cost of goods sold for the second quarter of 2021 of $133 million, with an offsetting reduction to beginning inventories. This charge resulted in a corresponding reduction to operating income, a $128 million reduction to net income, and an $0.11 reduction to diluted earnings per share for both the second quarter and the year ended 2021.

Property, Plant, and Equipment

Property, Plant, and Equipment	12 Months Ended
Property, Plant, and Equipment	Sep. 01, 2022
Property, Plant and Equipment [Abstract]
Property, Plant, and Equipment	Property, Plant, and Equipment As of 2022 2021 Land $ 280 $ 280 Buildings 16,676 14,776 Equipment (1) 61,354 51,902 Construction in progress (2) 1,897 1,517 Software 1,124 987 81,331 69,462 Accumulated depreciation (42,782) (36,249) $ 38,549 $ 33,213 (1) Includes costs related to equipment not placed into service of $3.35 billion as of September 1, 2022 and $1.99 billion as of September 2, 2021. (2) Includes building-related construction, tool installation, and software costs for assets not placed into service. Depreciation expense was $7.03 billion, $6.13 billion, and $5.57 billion for 2022, 2021, and 2020, respectively. Interest capitalized as part of the cost of property, plant, and equipment was $77 million, $66 million, and $77 million for 2022, 2021, and 2020, respectively.

Intangible Assets and Goodwill

Intangible Assets and Goodwill	12 Months Ended
Intangible Assets and Goodwill	Sep. 01, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets and Goodwill	Intangible Assets and Goodwill 2022 2021 As of Gross Accumulated Gross Accumulated Product and process technology $ 742 $ (321) $ 633 $ (284) Goodwill 1,228 1,228 In 2022, 2021, and 2020, we capitalized $158 million, $106 million, and $73 million, respectively, for product and process technology with weighted-average useful lives of 9 years, 9 years, and 10 years, respectively. Amortization expense was $85 million, $82 million, and $78 million for 2022, 2021, and 2020, respectively. Expected amortization expense is $83 million for 2023, $72 million for 2024, $52 million for 2025, $43 million for 2026, and $37 million for 2027.

Leases

Leases	12 Months Ended
Leases	Sep. 01, 2022
Leases [Abstract]
Leases	Leases We have finance and operating leases through which we obtain the right to use facilities, land, and equipment that support our business operations. Our finance leases consist primarily of gas or other supply agreements that are deemed to contain embedded leases. Our operating leases consist primarily of offices, laboratories, other facilities, and land. Certain of our operating leases include one or more options to extend the lease term for periods from one year to 10 years for real estate and one year to 30 years for land. Certain supply or service agreements require us to exercise significant judgment to determine whether the agreement contains a lease. Our assessment includes determining whether we or the supplier control the assets used to fulfill the agreements by identifying whether we or the supplier have the right to change the type, quantity, timing, or location of the output of the assets. Our gas supply arrangements generally are deemed to contain a lease because we have the right to substantially all of the output of the assets used to produce the supply and we have the right to change the quantity and timing of the output of those assets. In determining the lease term, we assess whether we are reasonably certain to exercise any options to renew or terminate a lease or to purchase the right-of-use asset. Measuring the present value of the initial lease liability requires judgment to determine the discount rate, which we base on interest rates for borrowings with similar terms and collateral issued by entities with credit ratings similar to ours. The components of lease cost are presented below: For the year ended 2022 2021 2020 Finance lease cost Amortization of right-of-use asset $ 99 $ 69 $ 140 Interest on lease liability 24 20 22 Operating lease cost (1) 125 108 102 $ 248 $ 197 $ 264 (1) Operating lease cost includes short-term and variable lease expenses, which were not material for the periods presented. Supplemental cash flow information related to leases was as follows: For the year ended 2022 2021 2020 Cash flows used for operating activities Finance leases $ 23 $ 21 $ 24 Operating leases (1) 110 106 39 Cash flows used for financing activities – Finance leases 103 85 248 Noncash acquisitions of right-of-use assets Finance leases 309 395 107 Operating leases 197 27 11 (1) Includes $48 million of reimbursements received for tenant improvements for 2020. Supplemental balance sheet information related to leases was as follows: As of 2022 2021 Finance lease right-of-use assets (included in property, plant, and equipment and assets held for sale) $ 904 $ 766 Current operating lease liabilities (included in accounts payable and accrued expenses) 60 55 Weighted-average remaining lease term (in years) Finance leases 12 11 Operating leases 12 12 Weighted-average discount rate Finance leases 2.65 % 3.14 % Operating leases 2.90 % 2.63 % As of September 1, 2022, maturities of lease liabilities were as follows: For the year ending Finance Leases Operating Leases 2023 $ 123 $ 66 2024 100 80 2025 87 70 2026 87 67 2027 86 64 2028 and thereafter 534 463 Less imputed interest (131) (140) $ 886 $ 670 The table above excludes obligations for leases that have been executed but have not yet commenced. As of September 1, 2022, excluded obligations consisted of $212 million of finance lease obligations over a weighted-average period of 14 years for gas supply arrangements deemed to contain embedded leases. We will recognize right-of-use assets and associated lease liabilities at the time such assets become available for our use.
Leases	Leases We have finance and operating leases through which we obtain the right to use facilities, land, and equipment that support our business operations. Our finance leases consist primarily of gas or other supply agreements that are deemed to contain embedded leases. Our operating leases consist primarily of offices, laboratories, other facilities, and land. Certain of our operating leases include one or more options to extend the lease term for periods from one year to 10 years for real estate and one year to 30 years for land. Certain supply or service agreements require us to exercise significant judgment to determine whether the agreement contains a lease. Our assessment includes determining whether we or the supplier control the assets used to fulfill the agreements by identifying whether we or the supplier have the right to change the type, quantity, timing, or location of the output of the assets. Our gas supply arrangements generally are deemed to contain a lease because we have the right to substantially all of the output of the assets used to produce the supply and we have the right to change the quantity and timing of the output of those assets. In determining the lease term, we assess whether we are reasonably certain to exercise any options to renew or terminate a lease or to purchase the right-of-use asset. Measuring the present value of the initial lease liability requires judgment to determine the discount rate, which we base on interest rates for borrowings with similar terms and collateral issued by entities with credit ratings similar to ours. The components of lease cost are presented below: For the year ended 2022 2021 2020 Finance lease cost Amortization of right-of-use asset $ 99 $ 69 $ 140 Interest on lease liability 24 20 22 Operating lease cost (1) 125 108 102 $ 248 $ 197 $ 264 (1) Operating lease cost includes short-term and variable lease expenses, which were not material for the periods presented. Supplemental cash flow information related to leases was as follows: For the year ended 2022 2021 2020 Cash flows used for operating activities Finance leases $ 23 $ 21 $ 24 Operating leases (1) 110 106 39 Cash flows used for financing activities – Finance leases 103 85 248 Noncash acquisitions of right-of-use assets Finance leases 309 395 107 Operating leases 197 27 11 (1) Includes $48 million of reimbursements received for tenant improvements for 2020. Supplemental balance sheet information related to leases was as follows: As of 2022 2021 Finance lease right-of-use assets (included in property, plant, and equipment and assets held for sale) $ 904 $ 766 Current operating lease liabilities (included in accounts payable and accrued expenses) 60 55 Weighted-average remaining lease term (in years) Finance leases 12 11 Operating leases 12 12 Weighted-average discount rate Finance leases 2.65 % 3.14 % Operating leases 2.90 % 2.63 % As of September 1, 2022, maturities of lease liabilities were as follows: For the year ending Finance Leases Operating Leases 2023 $ 123 $ 66 2024 100 80 2025 87 70 2026 87 67 2027 86 64 2028 and thereafter 534 463 Less imputed interest (131) (140) $ 886 $ 670 The table above excludes obligations for leases that have been executed but have not yet commenced. As of September 1, 2022, excluded obligations consisted of $212 million of finance lease obligations over a weighted-average period of 14 years for gas supply arrangements deemed to contain embedded leases. We will recognize right-of-use assets and associated lease liabilities at the time such assets become available for our use.

Accounts Payable and Accrued Ex

Accounts Payable and Accrued Expenses	12 Months Ended
Accounts Payable and Accrued Expenses	Sep. 01, 2022
Payables and Accruals [Abstract]
Accounts Payable and Accrued Expenses	Accounts Payable and Accrued Expenses As of 2022 2021 Accounts payable $ 2,142 $ 1,744 Property, plant, and equipment 2,170 1,887 Salaries, wages, and benefits 877 984 Income and other taxes 420 364 Other 481 346 $ 6,090 $ 5,325

Debt

Debt	12 Months Ended
Debt	Sep. 01, 2022
Debt Disclosure [Abstract]
Debt	Debt 2022 2021 Net Carrying Amount Net Carrying Amount As of Stated Rate Effective Rate Principal Current Long-Term Total Principal Current Long-Term Total 2024 Term Loan A 3.700 % 3.74 % $ 1,188 $ — $ 1,187 $ 1,187 $ 1,188 $ — $ 1,186 $ 1,186 2026 Notes 4.975 % 5.07 % 500 — 498 498 500 — 498 498 2027 Notes (1) 4.185 % 4.27 % 900 — 806 806 900 — 901 901 2029 Notes 5.327 % 5.40 % 700 — 697 697 700 — 696 696 2030 Notes 4.663 % 4.73 % 850 — 846 846 850 — 846 846 2032 Green Bonds 2.703 % 2.77 % 1,000 — 994 994 — — — — 2041 Notes 3.366 % 3.41 % 500 — 496 496 — — — — 2051 Notes 3.477 % 3.52 % 500 — 496 496 — — — — Finance lease obligations N/A 2.65 % 886 103 783 886 804 155 649 804 2023 Notes N/A N/A — — — — 1,250 — 1,247 1,247 2024 Notes N/A N/A — — — — 600 — 598 598 $ 7,024 $ 103 $ 6,803 $ 6,906 $ 6,792 $ 155 $ 6,621 $ 6,776 (1) In 2021, we entered into fixed-to-floating interest rate swaps on the 2027 Notes with an aggregate $900 million notional amount equal to the principal amount of the 2027 Notes. The resulting variable interest paid is at a rate equal to SOFR plus approximately 3.33%. The fixed-to-floating interest rate swaps are accounted for as fair value hedges, as a result, the carrying values of our 2027 Notes reflect adjustments in fair value. As of September 1, 2022, all of our debt, other than our finance leases, are unsecured obligations that rank equally in right of payment with all of our other existing and future unsecured indebtedness and are effectively subordinated to all future secured indebtedness, to the extent of the value of the assets securing such indebtedness. As of September 1, 2022, Micron had unsecured debt with a carrying value of $6.02 billion that was structurally subordinated to all liabilities of its subsidiaries, including trade payables. The terms of our indebtedness generally contain cross payment default and cross acceleration provisions. Micron’s guarantees of certain liabilities of its subsidiaries are unsecured obligations ranking equally in right of payment with all of Micron’s other existing and future unsecured indebtedness. Senior Unsecured Notes On November 1, 2021, we issued $2.00 billion aggregate principal amount of unsecured 2032 Green Bonds, 2041 Notes, and 2051 Notes in a public offering. Issuance costs for these notes were $14 million. Over time, we plan to allocate an amount equal to the net proceeds of the 2032 Green Bonds to fund eligible sustainability-focused projects involving renewable energy, green buildings, energy efficiency, water management, waste abatement, and a circular economy. We may redeem our 2026 Notes, 2027 Notes, 2029 Notes, 2030 Notes, 2032 Green Bonds, 2041 Notes, and 2051 Notes (the “Senior Unsecured Notes”), in whole or in part, at our option prior to their respective maturity date at a redemption price equal to the greater of (i) 100% of the principal amount of the notes to be redeemed and (ii) the present value of the remaining scheduled payments of principal, in each case plus accrued interest. We may also redeem any series of our Senior Unsecured Notes, in whole or in part, at a price equal to par between two and six months prior to maturity in accordance with the respective terms of such series. Each series of Senior Unsecured Notes contains covenants that, among other things, limit, in certain circumstances, our ability and/or the ability of our restricted subsidiaries (which are generally domestic subsidiaries in which we own at least 80% of the voting stock and which own principal property, as defined in the indenture governing such notes) to (1) create or incur certain liens; (2) enter into certain sale and lease-back transactions; and (3) consolidate with or merge with or into, or convey, transfer, or lease all or substantially all of our properties and assets, to another entity. These covenants are subject to a number of limitations and exceptions. Additionally, if a change of control triggering event occurs, as defined in the indentures governing our senior unsecured notes, we will be required to offer to purchase such notes at 101% of the outstanding aggregate principal amount plus accrued interest up to the purchase date. Revolving Credit Facility In 2021, we terminated our existing undrawn credit facility and entered into a new five Under the terms of the Revolving Credit Facility, we must maintain a leverage ratio, calculated as of the last day of each fiscal quarter, of total indebtedness to adjusted EBITDA not to exceed 3.25 to 1.00. The Revolving Credit Facility contains other covenants that, among other things, limit, in certain circumstances, our ability and/or the ability of our restricted subsidiaries to (1) create or incur certain liens and enter into sale and lease-back transactions, (2) create, assume, incur, or guarantee certain additional secured indebtedness and unsecured indebtedness of our restricted subsidiaries, and (3) consolidate with or merge with or into, or convey, transfer, lease, or otherwise dispose of all or substantially all of our assets, to another entity. These covenants are subject to a number of limitations, exceptions, and qualifications. 2024 Term Loans In 2021, we drew $1.19 billion under an unsecured 2024 Term Loan A and used the proceeds to repay the $1.19 billion Extinguished 2024 Term Loan A. The 2024 Term Loan A bears interest at a rate equal to LIBOR plus 0.625% to 1.375% based on our current corporate credit ratings. The term loan agreement provides for a transition to SOFR or other alternate benchmark rate upon the retirement of LIBOR in 2023. The principal amount is due October 2024 and may be prepaid without penalty. The 2024 Term Loan A contains the same leverage ratio and substantially the same other covenants as the Revolving Credit Facility. Debt Activity The table below presents the effects of issuances and prepayments of debt in 2022: Increase (Decrease) in Principal Increase (Decrease) in Carrying Value Increase (Decrease) in Cash Gain (Loss) Issuances 2032 Green Bonds $ 1,000 $ 994 $ 994 $ — 2041 Notes 500 496 496 — 2051 Notes 500 496 496 — Prepayments 2023 Notes (1,250) (1,247) (1,281) (34) 2024 Notes (600) (598) (647) (49) $ 150 $ 141 $ 58 $ (83) In 2021, substantially all holders of our 2032D Notes converted their notes. We settled these conversions and all remaining 2032D Notes with $185 million in cash and 11.1 million shares of our stock, which approximated the carrying value of debt and equity for those notes. In 2020, we recognized aggregate non-operating gains of $40 million in connection with debt prepayments and conversions of $3.77 billion of principal amount of notes (carrying value of $3.90 billion) for an aggregate of $3.92 billion in cash. Maturities of Notes Payable As of September 1, 2022, maturities of notes payable by fiscal year were as follows: 2023 $ — 2024 — 2025 1,188 2026 500 2027 900 2028 and thereafter 3,550 Unamortized discounts (27) Hedge accounting fair value adjustment (91) $ 6,020

Commitments

Commitments	12 Months Ended
Commitments	Sep. 01, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments	Commitments As of September 1, 2022, we had commitments of approximately $7.1 billion for purchase obligations, of which approximately $5.4 billion will be due within one year. Purchase obligations include payments for the acquisition of property, plant, and equipment, and other goods or services of either a fixed or minimum quantity and exclude any payments for leases that have been executed but have not yet commenced.

Contingencies

Contingencies	12 Months Ended
Contingencies	Sep. 01, 2022
Loss Contingency [Abstract]
Contingencies	Contingencies We are currently a party to legal actions other than those described below arising from the normal course of business, none of which are expected to have a material adverse effect on our business, results of operations, or financial condition. Patent Matters As is typical in the semiconductor and other high-tech industries, from time to time, others have asserted, and may in the future assert, that our products or manufacturing processes infringe upon their intellectual property rights. On December 15, 2014, Innovative Memory Solutions, Inc. filed a patent infringement action against Micron in the U.S. District Court for the District of Delaware. The complaint alleges that a variety of our NAND products infringe eight U.S. patents and seeks damages, attorneys’ fees, and costs. Subsequently, six patents were invalidated or withdrawn, leaving two asserted patents in the District Court. On March 19, 2018, Micron Semiconductor (Xi’an) Co., Ltd. (“MXA”) was served with a patent infringement complaint filed by Fujian Jinhua Integrated Circuit Co., Ltd. (“Jinhua”) in the Fuzhou Intermediate People’s Court in Fujian Province, China (the “Fuzhou Court”). On April 3, 2018, Micron Semiconductor (Shanghai) Co. Ltd. (“MSS”) was served with the same complaint. The complaint alleges that MXA and MSS infringed one Chinese patent by manufacturing and selling certain Crucial DDR4 DRAM modules. The complaint seeks an order requiring MXA and MSS to destroy inventory of the accused products and equipment for manufacturing the accused products in China; to stop manufacturing, using, selling, and offering for sale the accused products in China; and to pay damages of 98 million Chinese yuan plus court fees incurred. On March 21, 2018, MXA was served with a patent infringement complaint filed by United Microelectronics Corporation (“UMC”) in the Fuzhou Court. On April 3, 2018, MSS was served with the same complaint. The complaint alleges that MXA and MSS infringed one Chinese patent by manufacturing and selling certain Crucial DDR4 DRAM modules. The complaint seeks an order requiring MXA and MSS to destroy inventory of the accused products and equipment for manufacturing the accused products in China; to stop manufacturing, using, selling, and offering for sale the accused products in China; and to pay damages of 90 million Chinese yuan plus court fees incurred. On November 26, 2021, pursuant to a settlement agreement between UMC and Micron, UMC filed an application to the Fuzhou Court to withdraw its complaints against MXA and MSS. On April 3, 2018, MSS was served with another patent infringement complaint filed by Jinhua and an additional complaint filed by UMC in the Fuzhou Court. The additional complaints allege that MSS infringes two Chinese patents by manufacturing and selling certain Crucial MX300 SSDs. The complaint filed by UMC seeks an order requiring MSS to destroy inventory of the accused products and equipment for manufacturing the accused products in China; to stop manufacturing, using, selling, and offering for sale the accused products in China; and to pay damages of 90 million Chinese yuan plus court fees incurred. The complaint filed by Jinhua seeks an order requiring MSS to destroy inventory of the accused products and equipment for manufacturing the accused products in China; to stop manufacturing, using, selling, and offering for sale the accused products in China; and to pay damages of 98 million Chinese yuan plus court fees incurred. On November 26, 2021, pursuant to a settlement agreement between UMC and Micron, UMC filed an application to the Fuzhou Court to withdraw its complaint against MSS. On July 5, 2018, MXA and MSS were notified that the Fuzhou Court granted a preliminary injunction against those entities that enjoins them from manufacturing, selling, or importing certain Crucial and Ballistix-branded DRAM modules and solid-state drives in China. We are complying with the ruling and have requested the Fuzhou Court to reconsider or stay its decision. On May 4, 2020, Flash-Control, LLC filed a patent infringement action against Micron in the U.S. District Court for the Western District of Texas. The complaint alleges that four U.S. patents are infringed by unspecified DDR4 SDRAM, NVRDIMM, NVDIMM, 3D XPoint, and/or SSD products that incorporate memory controllers and flash memory. The complaint seeks damages, attorneys’ fees, and costs. On July 21, 2020, in a separate matter, the District Court ruled that two of the four asserted patents are invalid, and on July 14, 2021, the U.S. Court of Appeals for the Federal Circuit affirmed the ruling of invalidity. On April 28, 2021, Netlist, Inc. (“Netlist”) filed two patent infringement actions against Micron, Micron Semiconductor Products, Inc. (“MSP”) and Micron Technology Texas, LLC (“MTEC”) in the U.S. District Court for the Western District of Texas. The first complaint alleges that one U.S. patent is infringed by certain of our non-volatile dual in-line memory modules. The second complaint alleges that three U.S. patents are infringed by certain of our load-reduced dual in-line memory modules (“LRDIMMs”). Each complaint seeks injunctive relief, damages, attorneys’ fees, and costs. On March 31, 2022, Netlist filed a patent infringement complaint against Micron and Micron Semiconductor Germany, GmbH in Dusseldorf Regional Court alleging that two German patents are infringed by certain of our LRDIMMs. The complaint seeks damages and costs. On June 24, 2022, Netlist amended its complaint to also seek injunctive relief. On June 10, 2022, Netlist filed a patent infringement complaint against Micron, MSP, and MTEC in the U.S. District Court for the Eastern District of Texas (“E.D. Tex.”) alleging that six U.S. patents are infringed by certain of our memory modules and HBM products. The complaint seeks injunctive relief, damages, and attorneys’ fees. On August 1, 2022, Netlist filed a second patent infringement complaint against Micron, MSP, and MTEC in E.D. Tex. alleging that one U.S. patent is infringed by certain of our LRDIMMs. On August 15, 2022, Netlist amended the second complaint to assert that two additional U.S. patents are infringed by certain of our LRDIMMs. The second complaint in E.D. Tex. seeks injunctive relief, damages, and attorneys’ fees. On May 10, 2021, Vervain, LLC filed a patent infringement action against Micron, MSP, and MTEC in the U.S. District Court for the Western District of Texas. The complaint alleges that four U.S. patents are infringed by certain SSD products. The complaint seeks injunctive relief, damages, attorneys’ fees, and costs. On April 27, 2022, Bell Semiconductor, LLC (“Bell”) filed a patent infringement action against Micron in the U.S. District Court for the District of Idaho. The complaint alleges that one U.S. patent is infringed by a certain SSD controller. On April 28, 2022, Bell filed a complaint with the U.S. International Trade Commission (“ITC”) alleging violations of Section 337 of the Tariff Act of 1930 based on alleged importation of articles and components that infringe the same U.S. patent that Bell asserts in the complaint it filed in the District of Idaho. At Bell’s request, the ITC investigation was terminated on August 30, 2022. On August 26, 2022, Bell filed a second patent infringement complaint in the District of Idaho alleging that two U.S. patents are infringed by a certain SSD controller. On September 30, 2022, Bell filed a complaint against Micron in the U.S. District Court for the District of Delaware alleging that six U.S. patents are infringed by certain SSD, GDDR5, GDDR6, GDDR6X, and DDR3 SDRAM products. On October 5, 2022, Bell filed a third complaint against Micron in the District of Idaho alleging that one U.S. patent is infringed by Micron’s process for designing a NAND flash device included in certain Micron SSD products. Each of Bell’s complaints in the District Courts seeks damages, injunctive relief, attorneys’ fees, and costs. On October 6, 2022, Bell filed a complaint with the ITC alleging violations of Section 337 of the Tariff Act of 1930 based on alleged importation of certain SSDs that infringe two U.S. patents also asserted by Bell in two of the lawsuits pending in the District of Idaho. The complaint requests institution of an investigation and, after the investigation, issuance of a limited exclusion order and cease and desist orders prohibiting Micron from importing, selling, offering for sale, or marketing the accused products in the United States. On August 16, 2022, Sonrai Memory Ltd. filed a patent infringement action against Micron in the U.S. District Court for the Western District of Texas. The complaint alleges that two U.S. patents are infringed by certain SSD and NAND flash products. The complaint seeks damages, attorneys’ fees, and costs. Among other things, the above lawsuits pertain to substantially all of our DRAM, NAND, and other memory and storage products we manufacture, which account for substantially all of our revenue. Qimonda On January 20, 2011, Dr. Michael Jaffé, administrator for Qimonda’s insolvency proceedings, filed suit against Micron and Micron Semiconductor B.V. (“Micron B.V.”), in the District Court of Munich, Civil Chamber. The complaint seeks to void, under Section 133 of the German Insolvency Act, a share purchase agreement between Micron B.V. and Qimonda signed in fall 2008, pursuant to which Micron B.V. purchased substantially all of Qimonda’s shares of Inotera (the “Inotera Shares”), representing approximately 18% of Inotera’s outstanding shares at that time, and seeks an order requiring us to re-transfer those shares to the Qimonda estate. The complaint also seeks, among other things, to recover damages for the alleged value of the joint venture relationship with Inotera and to terminate, under Sections 103 or 133 of the German Insolvency Code, a patent cross-license between us and Qimonda entered into at the same time as the share purchase agreement. Following a series of hearings with pleadings, arguments, and witnesses on behalf of the Qimonda estate, on March 13, 2014, the court issued judgments: (1) ordering Micron B.V. to pay approximately $1 million in respect of certain Inotera Shares sold in connection with the original share purchase; (2) ordering Micron B.V. to disclose certain information with respect to any Inotera Shares sold by it to third parties; (3) ordering Micron B.V. to disclose the benefits derived by it from ownership of the Inotera Shares, including in particular, any profits distributed on the Inotera Shares and all other benefits; (4) denying Qimonda’s claims against Micron for any damages relating to the joint venture relationship with Inotera; and (5) determining that Qimonda’s obligations under the patent cross-license agreement are canceled. In addition, the court issued interlocutory judgments ordering, among other things: (1) that Micron B.V. transfer to the Qimonda estate the Inotera Shares still owned by Micron B.V. and pay to the Qimonda estate compensation in an amount to be specified for any Inotera Shares sold to third parties; and (2) that Micron B.V. pay the Qimonda estate as compensation an amount to be specified for benefits derived by Micron B.V. from ownership of the Inotera Shares. The interlocutory judgments had no immediate, enforceable effect and Micron, accordingly, has been able to continue to operate with full control of the Inotera Shares subject to further developments in the case. Micron and Micron B.V. appealed the judgments to the German Appeals Court, which thereafter appointed an independent expert to perform an evaluation of Dr. Jaffé’s claims that the amount Micron paid for Qimonda was less than fair market value. On March 31, 2020, the expert presented an opinion to the Appeals Court concluding that the amount paid by Micron was within an acceptable range of fair value. On October 5, 2022, the Appeals Court ruled that the relevant issue to be addressed is whether Qimonda's creditors were prejudiced such that the original transaction should be voided. A hearing of the Appeals Court has been scheduled for December 2022. Antitrust Matters On April 27, 2018, a complaint was filed against Micron and other DRAM suppliers in the U.S. District Court for the Northern District of California. Subsequently, two substantially identical cases were filed in the same court. The lawsuits purported to be on behalf of a nationwide class of indirect purchasers of DRAM products. On October 28, 2019, the plaintiffs filed a consolidated, amended complaint that purported to be on behalf of a nationwide class of indirect purchasers of DRAM products. The amended complaint asserted claims based on alleged price-fixing of DRAM products under federal and state law during the period from June 1, 2016 to at least February 1, 2018, and sought treble monetary damages, costs, interest, attorneys’ fees, and other injunctive and equitable relief. On December 21, 2020, the District Court dismissed the plaintiffs’ claims and entered judgment against them. The plaintiffs appealed to the U.S. Court of Appeals for the Ninth Circuit. On March 7, 2022, the Court of Appeals affirmed the District Court’s ruling dismissing plaintiffs’ claims, and subsequently denied the plaintiffs’ request for rehearing. The plaintiffs did not further appeal the ruling of the Court of Appeals. On June 26, 2018, a complaint was filed against Micron and other DRAM suppliers in the U.S. District Court for the Northern District of California. Subsequently, four substantially identical cases were filed in the same court. On October 28, 2019, the plaintiffs filed a consolidated, amended complaint. The consolidated complaint purported to be on behalf of a nationwide class of direct purchasers of DRAM products. The consolidated complaint asserted claims based on alleged price-fixing of DRAM products under federal and state law during the period from June 1, 2016 through at least February 1, 2018, and sought treble monetary damages, costs, interest, attorneys’ fees, and other injunctive and equitable relief. On January 11, 2021, the plaintiffs filed a further amended complaint asserting substantially the same claims and seeking the same relief. On September 3, 2021, the District Court granted Micron’s motion to dismiss the further amended complaint with prejudice. On October 1, 2021, the plaintiffs filed a notice of appeal to the U.S. Court of Appeals for the Ninth Circuit. On June 29, 2022, the Court of Appeals granted a joint motion to dismiss the plaintiffs’ appeal. Additionally, six cases have been filed in the following Canadian courts on the dates indicated: Superior Court of Quebec (April 30, 2018 and May 3, 2018), the Federal Court of Canada (May 2, 2018), the Ontario Superior Court of Justice (May 15, 2018), and the Supreme Court of British Columbia (May 10, 2018). The plaintiffs in these cases are individuals seeking certification of class actions on behalf of direct and indirect purchasers of DRAM in Canada (or regions of Canada) between June 1, 2016 and February 1, 2018. The substantive allegations in these cases are similar to those asserted in the cases filed in the United States. On May 15, 2018, the Chinese State Administration for Market Regulation (“SAMR”) notified Micron that it was investigating potential collusion and other anticompetitive conduct by DRAM suppliers in China. On May 31, 2018, SAMR made unannounced visits to our sales offices in Beijing, Shanghai, and Shenzhen to seek certain information as part of its investigation. We are cooperating with SAMR in its investigation. Securities Matters On March 5, 2019, a derivative complaint was filed by a shareholder against certain current and former officers and directors of Micron, allegedly on behalf of and for the benefit of Micron, in the U.S. District Court for the District of Delaware alleging securities fraud, breaches of fiduciary duties, and other violations of law involving misrepresentations about purported anticompetitive behavior in the DRAM industry. The complaint seeks damages, fees, interest, costs, and other appropriate relief. On February 9, 2021, a derivative complaint was filed by a shareholder against Sanjay Mehrotra and other current and former directors of Micron, allegedly on behalf of and for the benefit of Micron, in the U.S. District Court for the District of Delaware alleging violations of securities laws, breaches of fiduciary duties, and other violations of law involving allegedly false and misleading statements about Micron’s commitment to diversity and progress in diversifying its workforce, executive leadership, and Board of Directors. The complaint seeks damages, fees, interest, costs, and an order requiring Micron to take various actions to allegedly improve its corporate governance and internal procedures. Other Matters In the normal course of business, we are a party to a variety of agreements pursuant to which we may be obligated to indemnify another party. It is not possible to predict the maximum potential amount of future payments under these types of agreements due to the conditional nature of our obligations and the unique facts and circumstances involved in each particular agreement. Historically, our payments under these types of agreements have not had a material adverse effect on our business, results of operations, or financial condition. Contingency Assessment We are unable to predict the outcome of any of the matters noted above and cannot make a reasonable estimate of the potential loss or range of possible losses. A determination that our products or manufacturing processes infringe the intellectual property rights of others or entering into a license agreement covering such intellectual property could result in significant liability and/or require us to make material changes to our products and/or manufacturing processes. Any of the foregoing, as well as the resolution of any other legal matter noted above, could have a material adverse effect on our business, results of operations, or financial condition.

Equity

Equity	12 Months Ended
Equity	Sep. 01, 2022
Equity [Abstract]
Equity	Equity Common Stock Repurchases : Our Board of Directors has authorized the discretionary repurchase of up to $10 billion of our outstanding common stock through open-market purchases, block trades, privately-negotiated transactions, derivative transactions, and/or pursuant to Rule 10b5-1 trading plans. The repurchase authorization has no expiration date, does not obligate us to acquire any common stock, and is subject to market conditions and our ongoing determination of the best use of available cash. We repurchased 35.4 million shares of our common stock for $2.43 billion in 2022 and 15.6 million shares for $1.20 billion in 2021. Through September 1, 2022, we had repurchased an aggregate of $6.47 billion under the authorization. Amounts repurchased are included in treasury stock. Dividends : On September 29, 2022, we announced that our Board of Directors had declared a quarterly dividend of $0.115 per share, payable in cash on October 26, 2022, to shareholders of record as of the close of business on October 11, 2022. Accumulated Other Comprehensive Income (Loss) : Changes in accumulated other comprehensive income (loss) by component for the year ended September 1, 2022 were as follows: Gains (Losses) on Derivative Instruments Unrealized Gains (Losses) on Investments Pension Liability Adjustments Cumulative Foreign Currency Translation Adjustment Total As of September 2, 2021 $ (22) $ 1 $ 22 $ 1 $ 2 Other comprehensive income before reclassifications (720) (63) 6 (1) (778) Amount reclassified out of accumulated other comprehensive income 53 1 (2) — 52 Tax effects 151 14 (1) — 164 Other comprehensive income (loss) (516) (48) 3 (1) (562) As of September 1, 2022 $ (538) $ (47) $ 25 $ — $ (560)

Fair Value Measurements

Fair Value Measurements	12 Months Ended
Fair Value Measurements	Sep. 01, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The estimated fair values and carrying values of our outstanding debt instruments were as follows: 2022 2021 As of Fair Carrying Fair Carrying Notes $ 5,472 $ 6,020 $ 6,584 $ 5,973 The fair values of our debt instruments were estimated based on Level 2 inputs, including the trading price of our notes when available, discounted cash flows, and interest rates based on similar debt issued by parties with credit ratings similar to ours. Assets classified as held for sale are carried at the lower of estimated fair value or carrying value. Significant judgments and assumptions are required to estimate their fair values. Actual selling prices could vary significantly from our estimated fair value and we could recognize additional losses in the event that the sales prices of assets classified as held for sale are lower than their carrying values.

Derivative Instruments

Derivative Instruments	12 Months Ended
Derivative Instruments	Sep. 01, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments	Derivative Instruments Notional or Contractual Amount Fair Value of Assets (1) Liabilities (2) As of September 1, 2022 Derivative instruments with hedge accounting designation Cash flow currency hedges $ 5,427 $ — $ (330) Cash flow commodity hedges 97 1 (6) Fair value interest rate hedges 900 — (91) Derivative instruments without hedge accounting designation Non-designated currency hedges 2,821 7 (13) $ 8 $ (440) As of September 2, 2021 Derivative instruments with hedge accounting designation Cash flow currency hedges $ 3,601 $ 10 $ (66) Cash flow commodity hedges 45 2 — Fair value interest rate hedges 900 5 — Derivative instruments without hedge accounting designation Non-designated currency hedges 996 3 (2) $ 20 $ (68) (1) Included in receivables and other noncurrent assets. (2) Included in accounts payable and accrued expenses and other noncurrent liabilities. Derivative Instruments with Hedge Accounting Designation Cash Flow Hedges : We utilize forward and swap contracts that generally mature within two years designated as cash flow hedges to minimize our exposure to changes in currency exchange rates or commodity prices for certain capital expenditures and manufacturing costs. Forward and swap contracts are measured at fair value based on market-based observable inputs including market spot and forward rates, interest rates, and credit-risk spreads (Level 2). We do not use derivative instruments for speculative purposes. We recognized losses from cash flow hedges of $735 million and $52 million for 2022 and 2021, respectively, and gains of $51 million for 2020, in accumulated other comprehensive income. We reclassified $53 million of losses and $41 million of gains in 2022 and 2021, respectively, from accumulated other comprehensive income to earnings, primarily to cost of goods sold. The reclassifications were not significant in 2020. As of September 1, 2022, we expect to reclassify $263 million of pre-tax losses related to cash flow hedges from accumulated other comprehensive income into earnings in the next 12 months. Fair Value Hedges : We utilize fixed-to-floating interest rate swaps designated as fair value hedges to minimize certain exposures to changes in the fair value of fixed-rate debt that result from fluctuations in benchmark interest rates. Interest rate swaps are measured at fair value based on market-based observable inputs including interest rates and credit-risk spreads (Level 2). The changes in the fair values of derivatives designated as fair value hedges and the offsetting changes in the underlying fair values of the hedged items are both recognized in earnings. When a derivative is no longer designated as a fair value hedge for any reason, including termination and maturity, the remaining unamortized difference between the carrying value of the hedged item at that time and the face value of the hedged item is amortized to earnings over the remaining life of the hedged item, or immediately if the hedged item has matured or been extinguished. We recognized interest expense of $96 million for changes in the fair value of our interest rate swaps in 2022. We also recognized offsetting interest expense of the same amounts related to the changes in the fair value of the hedged portion of the underlying debt for these periods. The amounts recognized for 2021 were not significant. Derivative Instruments without Hedge Accounting Designation Currency Derivatives : We generally utilize a rolling hedge strategy with currency forward contracts that mature within three months to hedge our exposures of monetary assets and liabilities from changes in currency exchange rates. At the end of each reporting period, monetary assets and liabilities denominated in currencies other than the U.S. dollar are remeasured into U.S. dollars and the associated outstanding forward contracts are marked to market. Currency forward contracts are valued at fair values based on the middle of bid and ask prices of dealers or exchange quotations (Level 2). Realized and unrealized gains and losses on derivative instruments without hedge accounting designation as well as the changes in the underlying monetary assets and liabilities from changes in currency exchange rates are included in other non-operating income (expense), net. The amounts recognized for derivative instruments without hedge accounting designation were not significant for the periods presented. Derivative Counterparty Credit Risk and Master Netting Arrangements Our derivative instruments expose us to credit risk to the extent counterparties may be unable to meet the terms of the contracts. Our maximum exposure to loss due to credit risk if counterparties fail completely to perform according to the terms of the contracts would generally equal the fair value of assets for these contracts as listed in the tables above. We seek to mitigate such risk by limiting our counterparties to major financial institutions and by spreading risk across multiple financial institutions. As of September 1, 2022 and September 2, 2021, amounts netted under our master netting arrangements were not significant.

Equity Plans

Equity Plans	12 Months Ended
Equity Plans	Sep. 01, 2022
Share-Based Payment Arrangement [Abstract]
Equity Plans	Equity Plans As of September 1, 2022, 90 million shares of our common stock were available for future awards under our equity plans, including 18 million shares approved for issuance under our employee stock purchase plan (“ESPP”). Restricted Stock and Restricted Stock Units (“Restricted Stock Awards”) As of September 1, 2022, there were 23 million shares of Restricted Stock Awards outstanding, 20 million of which contained only service conditions. For service-based Restricted Stock Awards granted through October 2021, restrictions generally lapse in one-fourth or one-third increments during each year of employment after the grant date. For service-based Restricted Stock Awards granted beginning in November 2021, restrictions generally lapse on 25% of the units granted after the first year and on 6.25% each quarter thereafter over the remaining three years of employment. Restrictions generally lapse on Restricted Stock with performance or market conditions as conditions are met over a 3-year period. At the end of the performance period, the number of actual shares to be awarded will vary between 0% and 200% of target amounts, depending upon the achievement level. In 2022, our Board of Directors approved dividend equivalent rights for unvested restricted stock units awarded on or after October 13, 2021. Restricted Stock Awards activity for 2022 is summarized as follows: Number of Shares Weighted-Average Grant Date Fair Value Per Share Outstanding as of September 2, 2021 20 $ 49.39 Granted 13 70.81 Restrictions lapsed (7) 47.36 Canceled (3) 57.00 Outstanding as of September 1, 2022 23 60.93 For the year ended 2022 2021 2020 Restricted stock award shares granted 13 11 8 Weighted-average grant-date fair value per share $ 70.81 $ 53.58 $ 46.44 Aggregate vesting-date fair value of shares vested $ 498 $ 385 $ 294 Employee Stock Purchase Plan (“ESPP”) Our ESPP is offered to substantially all employees and permitted eligible employees to purchase shares of our common stock through payroll deductions of up to 10% of their eligible compensation, subject to certain limitations prior to August 2021. Beginning in August 2021, employees are permitted to deduct up to 15% of their eligible compensation to purchase shares under the ESPP. The purchase price of the shares under the ESPP equals 85% of the lower of the fair market value of our common stock on either the first or last day of each six For the year ended 2022 2021 2020 Weighted-average grant-date fair value per share $ 18.87 $ 20.71 $ 14.24 Average expected life in years 0.5 0.5 0.5 Weighted-average expected volatility (based on implied volatility) 43 % 41 % 45 % Weighted-average risk-free interest rate 2.0 % 0.1 % 0.8 % Expected dividend yield 0.6 % 0.3 % 0.0 % Under the ESPP, employees purchased 4 million shares of common stock for $215 million in 2022, 3 million shares for $140 million in 2021, and 3 million shares for $118 million in 2020. Stock Options As of September 1, 2022, stock options of 3 million shares were outstanding, all of which were fully exercisable. Stock options expire 8 years from the date of grant. We did not grant any stock options in 2022, 2021, or 2020. Stock options of 1 million shares were exercised in 2022. The total intrinsic value for options exercised was $54 million, $143 million, and $130 million in 2022, 2021, and 2020, respectively. Stock-based Compensation Expense For the year ended 2022 2021 2020 Stock-based compensation expense by caption Cost of goods sold $ 193 $ 186 $ 139 Research and development 175 110 86 Selling, general, and administrative 133 99 103 Restructure (5) — — $ 496 $ 395 $ 328 Stock-based compensation expense by type of award Restricted stock awards $ 429 $ 333 $ 272 ESPP 66 52 39 Stock options 1 10 17 $ 496 $ 395 $ 328

Employee Benefit Plans

Employee Benefit Plans	12 Months Ended
Employee Benefit Plans	Sep. 01, 2022
Retirement Benefits [Abstract]
Employee Benefit Plans	Employee Benefit Plans We have employee retirement plans at our U.S. and international sites. Details of significant plans are as follows: Employee Savings Plan for U.S. Employees We have a 401(k) retirement plan under which U.S. employees may contribute up to 75% of their eligible pay, subject to Internal Revenue Service annual contribution limits, to various savings alternatives, none of which include direct investment in our stock. We match in cash eligible contributions from employees up to 5% of the employee’s annual eligible earnings. Contribution expense for the 401(k) plan was $66 million, $77 million, and $66 million in 2022, 2021, and 2020, respectively. Retirement Plans We have pension plans available to employees at various foreign sites. As of September 1, 2022, the projected benefit obligations of our plans were $186 million and plan assets were $221 million. As of September 2, 2021, the projected benefit obligations of our plans were $222 million and plan assets were $256 million. Pension expense was not material for 2022, 2021, or 2020.

Revenue

Revenue	12 Months Ended
Revenue	Sep. 01, 2022
Revenue from Contract with Customer [Abstract]
Revenue	Revenue Revenue is primarily recognized at a point in time when control of the promised goods is transferred to our customers in an amount that reflects the consideration we expect to be entitled to in exchange for those goods. Substantially all contracts with our customers are short-term in duration at fixed, negotiated prices with payment generally due shortly after delivery. From time to time, we have contracts with initial terms that include performance obligations that extend beyond one year. As of September 1, 2022, our future performance obligations beyond one year were not significant. As of September 1, 2022 and September 2, 2021, other current liabilities included $1.26 billion and $846 million for estimates of consideration payable to customers, respectively, including estimates for pricing adjustments and returns. Revenue by Technology For the year ended 2022 2021 2020 DRAM $ 22,386 $ 20,039 $ 14,510 NAND 7,811 7,007 6,131 Other (primarily 3D XPoint memory and NOR) 561 659 794 $ 30,758 $ 27,705 $ 21,435

Restructure and Asset Impairmen

Restructure and Asset Impairments	12 Months Ended
Restructure and Asset Impairments	Sep. 01, 2022
Restructuring and Related Activities [Abstract]
Restructure and Asset Impairments	Restructure and Asset Impairments For the year ended 2022 2021 2020 Restructure and asset impairments $ 48 $ 488 $ 60 Restructure and asset impairments for 2022 and 2021 are primarily related to the sale of our Lehi, Utah facility. See “Lehi, Utah Fab and 3D XPoint.” Restructure and asset impairments for 2020 primarily related to asset impairments and employee relocation and severance costs related to right-sizing our Lehi, Utah facility.

Other Operating (Income) Expens

Other Operating (Income) Expense, Net	12 Months Ended
Other Operating (Income) Expense, Net	Sep. 01, 2022
Other Income and Expenses [Abstract]
Other Operating (Income) Expense, Net	Other Operating (Income) Expense, Net For the year ended 2022 2021 2020 Patent license charges $ — $ 128 $ — (Gain) loss on disposition of property, plant, and equipment (41) (24) (3) Other 7 (9) 11 $ (34) $ 95 $ 8

Other Non-Operating Income (Exp

Other Non-Operating Income (Expense), Net	12 Months Ended
Other Non-Operating Income (Expense), Net	Sep. 01, 2022
Other Nonoperating Income (Expense) [Abstract]
Other Non-Operating Income (Expense), Net	Other Non-Operating Income (Expense), Net For the year ended 2022 2021 2020 Gain (loss) on investments $ 26 $ 82 $ 22 Gain (loss) on debt prepayments, repurchases, and conversions (83) (1) 40 Other 19 — (2) $ (38) $ 81 $ 60

Income Taxes

Income Taxes	12 Months Ended
Income Taxes	Sep. 01, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Our income tax (provision) benefit consisted of the following: For the year ended 2022 2021 2020 Income (loss) before income taxes, net income (loss) attributable to noncontrolling interests, and equity in net income (loss) of equity method investees U.S. $ 112 $ (211) $ 308 Foreign 9,459 6,429 2,675 $ 9,571 $ 6,218 $ 2,983 Income tax (provision) benefit Current U.S. federal $ (65) $ (42) $ (20) State (1) (1) (2) Foreign (528) (370) (148) (594) (413) (170) Deferred U.S. federal (166) (9) 39 State (225) 28 23 Foreign 97 — (172) (294) 19 (110) Income tax (provision) benefit $ (888) $ (394) $ (280) The table below reconciles our tax (provision) benefit based on the U.S. federal statutory rate to our effective rate: For the year ended 2022 2021 2020 U.S. federal income tax (provision) benefit at statutory rate $ (2,010) 21.0 % $ (1,306) 21.0 % $ (626) 21.0 % U.S. tax on foreign operations (322) 3.4 % (226) 3.6 % (14) 0.5 % Change in valuation allowance (241) 2.5 % 54 (0.9) % (20) 0.7 % Change in unrecognized tax benefits (67) 0.7 % (238) 3.8 % (33) 1.1 % Foreign tax rate differential 1,601 (16.7) % 951 (15.3) % 253 (8.5) % Research and development tax credits 66 (0.7) % 123 (2.0) % 62 (2.1) % Foreign derived intangible income deduction 41 (0.4) % 18 (0.3) % 67 (2.2) % State taxes, net of federal benefit — — % 59 (0.9) % 23 (0.8) % Debt premium deductions — — % 130 (2.1) % — — % Other 44 (0.5) % 41 (0.6) % 8 (0.3) % Income tax (provision) benefit $ (888) 9.3 % $ (394) 6.3 % $ (280) 9.4 % We operate in a number of jurisdictions outside the United States, including Singapore, where we have tax incentive arrangements. These incentives expire, in whole or in part, at various dates through 2034 and are conditional, in part, upon meeting certain business operations and employment thresholds. The effect of tax incentive arrangements reduced our tax provision by $1.12 billion (benefiting our diluted earnings per share by $1.00) for 2022, by $758 million ($0.66 per diluted share) for 2021, and by $215 million ($0.19 per diluted share) for 2020. As of September 1, 2022, certain non-U.S. subsidiaries had cumulative undistributed earnings of $4.38 billion that were deemed to be indefinitely reinvested. A provision has not been recognized to the extent that distributions from such subsidiaries are subject to additional foreign withholding or state income tax. Determination of the amount of unrecognized deferred tax liabilities related to investments in these foreign subsidiaries is not practicable. Deferred income taxes reflect the net tax effects of temporary differences between the bases of assets and liabilities for financial reporting and income tax purposes as well as carryforwards. Deferred tax assets and liabilities consist of the following: As of 2022 2021 Deferred tax assets Net operating loss and tax credit carryforwards $ 796 $ 783 Accrued salaries, wages, and benefits 157 206 Operating lease liabilities 138 109 Inventories 77 — Property, plant, and equipment 44 37 Other 142 115 Gross deferred tax assets 1,354 1,250 Less valuation allowance (471) (233) Deferred tax assets, net of valuation allowance 883 1,017 Deferred tax liabilities Right-of-use assets (126) (90) Product and process technology — (12) Other (68) (143) Deferred tax liabilities (194) (245) Net deferred tax assets $ 689 $ 772 Reported as Deferred tax assets $ 702 $ 782 Deferred tax liabilities (included in other noncurrent liabilities) (13) (10) Net deferred tax assets $ 689 $ 772 We assess positive and negative evidence for each jurisdiction to determine whether it is more likely than not that existing deferred tax assets will be realized. As of September 1, 2022, and September 2, 2021, we had a valuation allowance of $471 million and $233 million, respectively, against our net deferred tax assets, primarily related to carryforwards in U.S. states and Malaysia. Changes in 2022 in the valuation allowance were due to adjustments based on management's assessment of the realizability of tax credits, allowances and net operating losses based on a level that is more likely than not to be realized. On March 16, 2022, the Idaho governor signed a new law that changed the way corporations calculate Idaho taxable income. This new law is expected to reduce our Idaho taxable income, and consequently, we do not expect to utilize our tax credits in Idaho for the foreseeable future. As a result, we recorded a valuation allowance against our Idaho deferred tax assets and an increase to tax expense of $189 million in 2022. As of September 1, 2022, our net operating loss carryforward amounts and expiration periods, as reported to tax authorities, were as follows: Year of Expiration State Japan Malaysia Other Total 2023 - 2027 $ 44 $ 418 $ — $ 12 $ 474 2028 - 2032 377 234 — — 611 2033 - 2037 249 — — — 249 2038 - 2042 197 — — — 197 Indefinite 6 — 851 4 861 $ 873 $ 652 $ 851 $ 16 $ 2,392 As of September 1, 2022, our federal and state tax credit carryforward amounts and expiration periods, as reported to tax authorities, were as follows: Year of Tax Credit Expiration U.S. Federal State Total 2023 - 2027 $ — $ 46 $ 46 2028 - 2032 — 103 103 2033 - 2037 — 128 128 2038 - 2042 278 5 283 Indefinite — 115 115 $ 278 $ 397 $ 675 Below is a reconciliation of the beginning and ending amount of our unrecognized tax benefits: For the year ended 2022 2021 2020 Beginning unrecognized tax benefits $ 660 $ 411 $ 383 Increases related to tax positions from prior years 14 2 14 Increases related to tax positions taken in current year 80 260 27 Decreases related to tax positions from prior years (23) (13) (13) Ending unrecognized tax benefits $ 731 $ 660 $ 411 As of September 1, 2022, gross unrecognized tax benefits were $731 million, which would have an impact of approximately $564 million on our effective tax rate in the future, if recognized. Amounts accrued for interest and penalties related to uncertain tax positions were not significant for any period presented. The resolution of tax audits or expiration of statute of limitations could also reduce our unrecognized tax benefits. Although the timing of final resolution is uncertain, the estimated potential reduction in our unrecognized tax benefits in the next 12 months would not be significant. We and our subsidiaries file income tax returns with the U.S. federal government, various U.S. states, and various foreign jurisdictions throughout the world. We regularly engage in discussions and negotiations with tax authorities regarding tax matters, including transfer pricing, and we continue to defend any and all such claims presented. Our U.S. federal and state tax returns remain open to examination for 2018 through 2022. We are currently under audit by the Internal Revenue Service for our 2018 and 2019 tax years. In addition, tax returns that remain open to examination in Singapore, Taiwan and Japan range from the years 2016 to 2022. We believe that adequate amounts of taxes and related interest and penalties have been provided, and any adjustments as a result of examinations are not expected to materially adversely affect our business, results of operations, or financial condition.

Earnings Per Share

Earnings Per Share	12 Months Ended
Earnings Per Share	Sep. 01, 2022
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share For the year ended 2022 2021 2020 Net income attributable to Micron – Basic $ 8,687 $ 5,861 $ 2,687 Assumed conversion of debt — — (4) Net income attributable to Micron – Diluted $ 8,687 $ 5,861 $ 2,683 Weighted-average common shares outstanding – Basic 1,112 1,120 1,110 Dilutive effect of equity plans and convertible notes 10 21 21 Weighted-average common shares outstanding – Diluted 1,122 1,141 1,131 Earnings per share Basic $ 7.81 $ 5.23 $ 2.42 Diluted 7.75 5.14 2.37 Antidilutive potential common shares excluded from the computation of diluted earnings per share, that could dilute basic earnings per share in the future, were as follows at the end of the periods shown: For the year ended 2022 2021 2020 Equity plans 5 2 5

Segment and Other Information

Segment and Other Information	12 Months Ended
Segment and Other Information	Sep. 01, 2022
Segment Reporting [Abstract]
Segment and Other Information	Segment and Other Information Segment information reported herein is consistent with how it is reviewed and evaluated by our chief operating decision maker. We have the following four business units, which are our reportable segments: Compute and Networking Business Unit (“CNBU”) : Includes memory products sold into client, cloud server, enterprise, graphics, and networking markets. Mobile Business Unit (“MBU”) : Includes memory and storage products sold into smartphone and other mobile-device markets. Embedded Business Unit (“EBU”) : Includes memory and storage products sold into automotive, industrial, and consumer markets. Storage Business Unit (“SBU”) : Includes SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets, and other discrete storage products sold in component and wafer form. Certain operating expenses directly associated with the activities of a specific segment are charged to that segment. Other indirect operating income and expenses are generally allocated to segments based on their respective percentage of cost of goods sold or forecasted wafer production. We do not identify or report internally our assets (other than goodwill) or capital expenditures by segment, nor do we allocate gains and losses from equity method investments, interest, other non-operating income or expense items, or taxes to segments. As of September 1, 2022 and September 2, 2021, CNBU, MBU, SBU, and EBU had goodwill of $832 million, $198 million, $101 million, and $97 million, respectively. For the year ended 2022 2021 2020 Revenue CNBU $ 13,693 $ 12,280 $ 9,184 MBU 7,260 7,203 5,702 EBU 5,235 4,209 2,759 SBU 4,553 3,973 3,765 All Other 17 40 25 $ 30,758 $ 27,705 $ 21,435 Operating income (loss) CNBU $ 5,844 $ 4,295 $ 2,010 MBU 2,160 2,173 1,074 EBU 1,752 1,006 301 SBU 513 173 36 All Other 12 20 (2) 10,281 7,667 3,419 Unallocated Stock-based compensation (501) (395) (328) Inventory accounting policy change to FIFO — (133) — Change in inventory cost absorption — (160) — 3D XPoint inventory write-down — (49) — Restructure and asset impairments (48) (488) (60) Patent license charges — (128) — Other (30) (31) (28) (579) (1,384) (416) Operating income $ 9,702 $ 6,283 $ 3,003 Depreciation and amortization expense included in operating income was as follows: For the year ended 2022 2021 2020 CNBU $ 2,766 $ 2,497 $ 2,318 MBU 1,725 1,553 1,436 EBU 1,280 1,028 741 SBU 1,323 1,101 1,115 All Other 2 8 12 Unallocated 20 27 28 $ 7,116 $ 6,214 $ 5,650

Certain Concentrations

Certain Concentrations	12 Months Ended
Certain Concentrations	Sep. 01, 2022
Risks and Uncertainties [Abstract]
Certain Concentrations	Certain Concentrations Revenue by market segment as an approximate percent of total revenue is presented in the table below: For the year ended 2022 2021 2020 Mobile 25 % 25 % 25 % Client and graphics 20 % 20 % 20 % Enterprise and cloud server 20 % 20 % 20 % SSDs and other storage 15 % 15 % 20 % Automotive, industrial, and consumer 15 % 15 % 15 % Revenue from Kingston Technology Company, Inc. was 12% and 11% of total revenue for 2022 and 2020, respectively. Revenue from WPG Holdings Limited was 11% and 13% of total revenue in 2022 and 2021, respectively. Sales to Kingston were primarily included in our CNBU and SBU segments; and sales to WPG were primarily included in our MBU, CNBU, and EBU segments. We generally have multiple sources of supply for our raw materials and production equipment; however, only a limited number of suppliers are capable of delivering certain raw materials and production equipment that meet our standards and, in some cases, materials or production equipment are provided by a single supplier. Financial instruments that potentially subject us to concentrations of credit risk consist principally of cash, money market accounts, certificates of deposit, fixed-rate debt securities, trade receivables, share repurchase, and derivative contracts. We invest through high-credit-quality financial institutions and, by policy, generally limit the concentration of credit exposure by restricting investments with any single obligor and monitoring credit risk of bank counterparties on an ongoing basis. A concentration of credit risk may exist with respect to receivables of certain customers. We perform ongoing credit evaluations of customers worldwide and generally do not require collateral from our customers. Historically, we have not experienced material losses on receivables. A concentration of risk may also exist with respect to our foreign currency hedges as the number of counterparties to our hedges is limited and the notional amounts are relatively large. We seek to mitigate such risk by limiting our counterparties to major financial institutions and through entering into master netting arrangements.

Geographic Information

Geographic Information	12 Months Ended
Geographic Information	Sep. 01, 2022
Segment Reporting [Abstract]
Geographic Information	Geographic Information Revenue based on the geographic location of our customers’ headquarters was as follows: For the year ended 2022 2021 2020 United States $ 16,026 $ 12,155 $ 10,381 Taiwan 6,185 6,606 3,657 Mainland China (excluding Hong Kong) 3,311 2,456 2,337 Japan 1,696 1,652 1,387 Hong Kong 1,665 2,582 1,792 Other Asia Pacific 1,223 1,420 1,157 Other 652 834 724 $ 30,758 $ 27,705 $ 21,435 Long-lived assets by geographic area consisted of property, plant, and equipment and right-of-use assets and were as follows: As of 2022 2021 Taiwan $ 13,143 $ 11,457 Singapore 12,045 9,411 Japan 7,113 7,222 United States (1) 5,155 5,205 Malaysia 994 757 China 440 436 Other 337 175 $ 39,227 $ 34,663 (1) Included $899 million (net of impairment) as of September 2, 2021 of property, plant, and equipment for our Lehi facility that was classified as held for sale and presented in other current assets.

Schedule II Valuation and Quali

Schedule II Valuation and Qualifying Accounts	12 Months Ended
Schedule II Valuation and Qualifying Accounts	Sep. 01, 2022
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]
Schedule II Valuation and Qualifying Accounts	SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS (In millions) Balance at Charged Currency Balance at Deferred Tax Asset Valuation Allowance Year ended September 1, 2022 $ 233 $ 241 $ (3) $ 471 Year ended September 2, 2021 294 (54) (7) 233 Year ended September 3, 2020 277 20 (3) 294

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	12 Months Ended
Significant Accounting Policies (Policies)	Sep. 01, 2022
Accounting Policies [Abstract]
Basis of Presentation	The accompanying consolidated financial statements include the accounts of Micron Technology, Inc. and our consolidated subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America.
Intercompany Eliminations	Intercompany balances and transactions have been eliminated in consolidation.
Reclassifications	Certain reclassifications have been made to prior period amounts to conform to current period presentation. See “Inventories” below for changes to our significant accounting policies, and the “Inventories” note for additional information.
Fiscal Period	Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Fiscal 2022 and 2021 each contained 52 weeks and fiscal 2020 contained 53 weeks. Our fourth quarter of fiscal 2020 contained 14 weeks and all other fiscal quarters in the years presented contained 13 weeks. All period references are to our fiscal periods unless otherwise indicated.
Derivative and Hedging Instruments	Derivative and Hedging Instruments We use derivative instruments to manage our exposure to changes in currency exchange rates from (1) our monetary assets and liabilities denominated in currencies other than the U.S. dollar and (2) forecasted cash flows for certain capital expenditures and manufacturing costs. We also use derivative instruments to manage our exposure to changes in commodity prices for manufacturing supplies and to minimize certain exposures to changes in the fair value of fixed-rate debt that result from fluctuations in benchmark interest rates. Derivative instruments are measured at their fair values and recognized as either assets or liabilities. The accounting for changes in the fair value of derivative instruments is based on the intended use of the derivative and the resulting designation. For derivative instruments that are not designated for hedge accounting, gains or losses from changes in fair values are recognized in other non-operating income (expense). For derivative instruments designated as cash flow hedges, gains or losses are included as a component of accumulated other comprehensive income and reclassified into earnings in the same line items and in the same periods in which the underlying transactions affect earnings. For derivative instruments designated as cash flow hedges, time value is excluded from the assessment of effectiveness and the gains and losses attributable to time value are recognized in earnings. For derivative instruments designated as fair value hedges, changes in the fair values of the derivative instruments and the offsetting changes in the fair values of the underlying hedged items are both recognized in earnings. We enter into master netting arrangements with our counterparties to mitigate credit risk in derivative hedge transactions. These master netting arrangements allow us and our counterparties to net settle amounts owed to each other. Derivative assets and liabilities that can be net settled with each counterparty have been presented in our consolidated balance sheet on a net basis.
Financial Instruments, Cash Equivalents	Financial InstrumentsCash equivalents include highly liquid short-term investments with original maturities to us of three months or less that are readily convertible to known amounts of cash.
Financial Instruments, Investments	Financial Instruments Cash equivalents include highly liquid short-term investments with original maturities to us of three months or less that are readily convertible to known amounts of cash. Other investments with remaining maturities of less than one year are included in short-term investments. Investments with remaining maturities greater than one year are included in long-term marketable investments. The carrying value of investment securities sold is determined using the specific identification method.
Functional Currency	Functional Currency The U.S. dollar is the functional currency for us and all of our consolidated subsidiaries.
Goodwill	Goodwill We perform an annual impairment assessment for goodwill in our fourth quarter each year.
Government Incentives	Government Incentives We receive incentives from governmental entities related to expenses, assets, and other activities. Our government incentives may require that we meet or maintain specified spending levels and other operational metrics and may be subject to reimbursement if such conditions are not met or maintained. Government incentives are recorded in the financial statements in accordance with their purpose: as a reduction of expenses, a reduction of asset costs, or other income. Incentives related to specific operating activities are offset against the related expense in the period the expense is incurred. Incentives related to the acquisition or construction of fixed assets are recognized as a reduction in the carrying amounts of the related assets and reduce depreciation expense over the useful lives of the assets. Other incentives are recognized as other operating income. Government incentives received prior to being earned are recognized in current or noncurrent deferred income or restricted cash, whereas government incentives earned prior to being received are recognized in current or noncurrent receivables. Cash received from government incentives related to operating expenses is included as an operating activity in the statement of cash flows, whereas cash received from incentives related to the acquisition of property, plant, and equipment is included as an investing activity.
Inventories	Inventories Effective as of the beginning of the second quarter of 2021, we changed the method of inventory costing from average cost to FIFO. The difference between average cost and FIFO was not material to any previously reported financial statements. Therefore, we have recognized the cumulative effect of the change as a reduction of inventories and a charge to cost of goods sold of $133 million as of the beginning of the second quarter of 2021. Inventories are stated at the lower of cost or net realizable value, with cost being determined on a FIFO basis. Cost includes depreciation, labor, material, and overhead costs, including product and process technology costs. When net realizable value (which requires projecting future average selling prices, sales volumes, and costs to complete products in work in process inventories) is below cost, we record a charge to cost of goods sold to write down inventories to their estimated net realizable value in advance of when inventories are actually sold. We review the major characteristics of product type and markets in determining the unit of account for which we perform the lower of cost or net realizable value analysis and categorize all inventories (including DRAM, NAND, and other memory) as a single group. We remove amounts from inventory and charge such amounts to cost of goods sold on a FIFO basis.
Leases	Leases We determine if an arrangement is a lease, or contains a lease, at the inception of the arrangement and evaluate whether the lease is an operating lease or a finance lease at the commencement date. We recognize right-of-use assets and lease liabilities for operating and finance leases with terms greater than 12 months. Right-of-use assets represent our right to use an asset for the lease term, while lease liabilities represent our obligation to make lease payments. We do not separate lease and non-lease components for real-estate and gas plant leases. Sublease income is included within lease expense.
Product and Process Technology	Product and Process Technology Costs incurred to (1) acquire product and process technology, (2) patent technology, and (3) maintain patent technology, are capitalized and amortized on a straight-line basis over periods ranging up to 12.5 years. We capitalize a portion of costs incurred to patent technology based on historical data of patents issued as a percent of patents we file. Product and process technology costs are amortized over the shorter of (1) the estimated useful life of the technology, (2) the patent term, or (3) the term of the technology agreement. Fully-amortized assets are removed from product and process technology and accumulated amortization.
Product Warranty	Product Warranty We generally provide a limited warranty that our products are in compliance with applicable specifications existing at the time of delivery. Under our standard terms and conditions of sale, liability for certain failures of product during a stated warranty period is usually limited to repair or replacement of defective items or return of, or a credit with respect to, amounts paid for such items. Under certain circumstances, we provide more extensive limited warranty coverage than that provided under our standard terms and conditions. Our warranty obligations are not material.
Property, Plant, and Equipment	Property, Plant, and Equipment Property, plant, and equipment is stated at cost and depreciated using the straight-line method over estimated useful lives of generally 10 to 30 years for buildings, 5 to 7 years for equipment, and 3 to 5 years for software. Assets held for sale are carried at the lower of estimated fair value or carrying value and are included in current assets. When property, plant, or equipment is retired or otherwise disposed, the net book value is removed and we recognize any gain or loss in results of operations. We capitalize interest on borrowings during the period of time we carry out the activities necessary to bring assets to the condition of their intended use and location. Capitalized interest becomes part of the cost of assets.
Interest Capitalization	We capitalize interest on borrowings during the period of time we carry out the activities necessary to bring assets to the condition of their intended use and location. Capitalized interest becomes part of the cost of assets.
Research and Development	Research and Development Costs related to the conceptual formulation and design of products and processes are charged to R&D expense as incurred. Development of a product is deemed complete when it is qualified through reviews and tests for performance and reliability. Subsequent to product qualification, product costs are included in cost of goods sold. Amounts from cost-sharing arrangements are reflected as a reduction of R&D expense.
Revenue Recognition	Revenue Recognition Revenue is primarily recognized at a point in time when control of the promised goods is transferred to our customers in an amount that reflects the consideration we expect to be entitled to in exchange for those goods. Contracts with our customers are generally short-term in duration at fixed, negotiated prices with payment generally due shortly after delivery. We estimate a liability for returns using the expected value method based on historical returns. In addition, we generally offer price protection to our distributors, which is a form of variable consideration that decreases the transaction price. We use the expected value method, based on historical price adjustments and current pricing trends, to estimate the amount of revenue recognized from sales to distributors. Differences between the estimated and actual amounts are recognized as adjustments to revenue.
Stock-based Compensation	Stock-based Compensation Stock-based compensation is measured at the grant date, based on the fair value of the award, and recognized as expense under the straight-line attribution method over the requisite service period. We account for forfeitures as they occur. We issue new shares upon the exercise of stock options, conversion of share units, or issuance of shares under our ESPP.
Treasury Stock	Treasury Stock Treasury stock is carried at cost. When we retire our treasury stock, any excess of the repurchase price paid over par value is allocated between additional capital and retained earnings.
Use of Estimates	Use of Estimates The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires our management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, expenses, and related disclosures. Estimates and judgments are based on historical experience, forecasted events, and various other assumptions that we believe to be reasonable under the circumstances. Estimates and judgments may differ under different assumptions or conditions. We evaluate our estimates and judgments on an ongoing basis. Actual results could differ from estimates.

Variable Interest Entities (Pol

Variable Interest Entities (Policies)	12 Months Ended
Variable Interest Entities (Policies)	Sep. 01, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Variable Interest Entities	We have interests in entities that are variable interest entities (“VIEs”). If we are the primary beneficiary of a VIE, we are required to consolidate it. To determine if we are the primary beneficiary, we evaluate whether we have the power to direct the activities that most significantly impact the VIE’s economic performance and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the VIE. Our evaluation includes identification of significant activities and an assessment of our ability to direct those activities based on governance provisions and arrangements to provide or receive product and process technology, product supply, operations services, equity funding, financing, and other applicable agreements and circumstances. Our assessments of whether we are the primary beneficiary of our VIEs require significant assumptions and judgments.

Segment Reporting (Policies)

Segment Reporting (Policies)	12 Months Ended
Segment Reporting (Policies)	Sep. 01, 2022
Segment Reporting [Abstract]
Segment Reporting Policy	Certain operating expenses directly associated with the activities of a specific segment are charged to that segment. Other indirect operating income and expenses are generally allocated to segments based on their respective percentage of cost of goods sold or forecasted wafer production. We do not identify or report internally our assets (other than goodwill) or capital expenditures by segment, nor do we allocate gains and losses from equity method investments, interest, other non-operating income or expense items, or taxes to segments.

Lehi, Utah Fab and 3D XPoint (T

Lehi, Utah Fab and 3D XPoint (Tables)	12 Months Ended
Lehi, Utah Fab and 3D XPoint (Tables)	Sep. 01, 2022
Lehi, Utah Facility
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Lehi, UT (Disposal Group) Assets Held for Sale	As of September 2, Property, plant, and equipment $ 1,334 Other current assets 50 Impairment (435) Lehi assets held for sale $ 949

Cash and Investments (Tables)

Cash and Investments (Tables)	12 Months Ended
Cash and Investments (Tables)	Sep. 01, 2022
Investments and Cash [Abstract]
Cash and Investments	All of our marketable debt investments were classified as available-for-sale as of the dates noted below. Cash and equivalents and the fair values of our available-for-sale investments, which approximated amortized costs, were as follows: 2022 2021 As of Cash and Equivalents Short-term Investments Long-term Marketable Investments (1) Total Fair Value Cash and Equivalents Short-term Investments Long-term Marketable Investments (1) Total Fair Value Cash $ 6,055 $ — $ — $ 6,055 $ 5,796 $ — $ — $ 5,796 Level 1 (2) Money market funds 1,196 — — 1,196 38 — — 38 Level 2 (3) Certificates of deposits 976 50 — 1,026 1,907 69 — 1,976 Corporate bonds — 759 995 1,754 9 429 1,134 1,572 Asset-backed securities — 20 608 628 8 95 509 612 Government securities 2 155 44 201 1 190 122 313 Commercial paper 33 85 — 118 4 87 — 91 8,262 $ 1,069 $ 1,647 $ 10,978 7,763 $ 870 $ 1,765 $ 10,398 Restricted cash (4) 77 66 Cash, cash equivalents, and restricted cash $ 8,339 $ 7,829 (1) The maturities of long-term marketable securities primarily range from one four years. (2) The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets. (3) The fair value of Level 2 securities is measured using information obtained from pricing services, which obtain quoted market prices for similar instruments, non-binding market consensus prices that are corroborated by observable market data, or various other methodologies, to determine the appropriate value at the measurement date. We perform supplemental analysis to validate information obtained from these pricing services. No adjustments were made to the fair values indicated by such pricing information as of September 1, 2022 or September 2, 2021.
Cash and equivalents and the fair values of available-for-sale investments	All of our marketable debt investments were classified as available-for-sale as of the dates noted below. Cash and equivalents and the fair values of our available-for-sale investments, which approximated amortized costs, were as follows: 2022 2021 As of Cash and Equivalents Short-term Investments Long-term Marketable Investments (1) Total Fair Value Cash and Equivalents Short-term Investments Long-term Marketable Investments (1) Total Fair Value Cash $ 6,055 $ — $ — $ 6,055 $ 5,796 $ — $ — $ 5,796 Level 1 (2) Money market funds 1,196 — — 1,196 38 — — 38 Level 2 (3) Certificates of deposits 976 50 — 1,026 1,907 69 — 1,976 Corporate bonds — 759 995 1,754 9 429 1,134 1,572 Asset-backed securities — 20 608 628 8 95 509 612 Government securities 2 155 44 201 1 190 122 313 Commercial paper 33 85 — 118 4 87 — 91 8,262 $ 1,069 $ 1,647 $ 10,978 7,763 $ 870 $ 1,765 $ 10,398 Restricted cash (4) 77 66 Cash, cash equivalents, and restricted cash $ 8,339 $ 7,829 (1) The maturities of long-term marketable securities primarily range from one four years. (2) The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets. (3) The fair value of Level 2 securities is measured using information obtained from pricing services, which obtain quoted market prices for similar instruments, non-binding market consensus prices that are corroborated by observable market data, or various other methodologies, to determine the appropriate value at the measurement date. We perform supplemental analysis to validate information obtained from these pricing services. No adjustments were made to the fair values indicated by such pricing information as of September 1, 2022 or September 2, 2021.

Receivables (Tables)

Receivables (Tables)	12 Months Ended
Receivables (Tables)	Sep. 01, 2022
Receivables [Abstract]
Schedule of Receivables	As of 2022 2021 Trade receivables $ 4,765 $ 4,920 Income and other taxes 251 264 Other 114 127 $ 5,130 $ 5,311

Inventories (Tables)

Inventories (Tables)	12 Months Ended
Inventories (Tables)	Sep. 01, 2022
Inventory Disclosure [Abstract]
Schedule of Inventories	As of 2022 2021 Finished goods $ 1,028 $ 513 Work in process 4,830 3,469 Raw materials and supplies 805 505 $ 6,663 $ 4,487

Property, Plant, and Equipment

Property, Plant, and Equipment (Tables)	12 Months Ended
Property, Plant, and Equipment (Tables)	Sep. 01, 2022
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant, and Equipment	As of 2022 2021 Land $ 280 $ 280 Buildings 16,676 14,776 Equipment (1) 61,354 51,902 Construction in progress (2) 1,897 1,517 Software 1,124 987 81,331 69,462 Accumulated depreciation (42,782) (36,249) $ 38,549 $ 33,213 (1) Includes costs related to equipment not placed into service of $3.35 billion as of September 1, 2022 and $1.99 billion as of September 2, 2021. (2) Includes building-related construction, tool installation, and software costs for assets not placed into service.

Intangible Assets and Goodwill

Intangible Assets and Goodwill (Tables)	12 Months Ended
Intangible Assets and Goodwill (Tables)	Sep. 01, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets and Goodwill	2022 2021 As of Gross Accumulated Gross Accumulated Product and process technology $ 742 $ (321) $ 633 $ (284) Goodwill 1,228 1,228

Leases (Tables)

Leases (Tables)	12 Months Ended
Leases (Tables)	Sep. 01, 2022
Leases [Abstract]
Schedule of Components of Lease Expense	For the year ended 2022 2021 2020 Finance lease cost Amortization of right-of-use asset $ 99 $ 69 $ 140 Interest on lease liability 24 20 22 Operating lease cost (1) 125 108 102 $ 248 $ 197 $ 264
Schedule of Other Lease Information	Supplemental cash flow information related to leases was as follows: For the year ended 2022 2021 2020 Cash flows used for operating activities Finance leases $ 23 $ 21 $ 24 Operating leases (1) 110 106 39 Cash flows used for financing activities – Finance leases 103 85 248 Noncash acquisitions of right-of-use assets Finance leases 309 395 107 Operating leases 197 27 11 (1) Includes $48 million of reimbursements received for tenant improvements for 2020. Supplemental balance sheet information related to leases was as follows: As of 2022 2021 Finance lease right-of-use assets (included in property, plant, and equipment and assets held for sale) $ 904 $ 766 Current operating lease liabilities (included in accounts payable and accrued expenses) 60 55 Weighted-average remaining lease term (in years) Finance leases 12 11 Operating leases 12 12 Weighted-average discount rate Finance leases 2.65 % 3.14 % Operating leases 2.90 % 2.63 %
Schedule of Finance Lease Maturities	For the year ending Finance Leases Operating Leases 2023 $ 123 $ 66 2024 100 80 2025 87 70 2026 87 67 2027 86 64 2028 and thereafter 534 463 Less imputed interest (131) (140) $ 886 $ 670
Schedule of Operating Lease Maturities	For the year ending Finance Leases Operating Leases 2023 $ 123 $ 66 2024 100 80 2025 87 70 2026 87 67 2027 86 64 2028 and thereafter 534 463 Less imputed interest (131) (140) $ 886 $ 670

Accounts Payable and Accrued _2

Accounts Payable and Accrued Expenses (Tables)	12 Months Ended
Accounts Payable and Accrued Expenses (Tables)	Sep. 01, 2022
Payables and Accruals [Abstract]
Schedule of Accounts Payable And Accrued Expenses	As of 2022 2021 Accounts payable $ 2,142 $ 1,744 Property, plant, and equipment 2,170 1,887 Salaries, wages, and benefits 877 984 Income and other taxes 420 364 Other 481 346 $ 6,090 $ 5,325

Debt (Tables)

Debt (Tables)	12 Months Ended
Debt (Tables)	Sep. 01, 2022
Debt Disclosure [Abstract]
Schedule of Debt	2022 2021 Net Carrying Amount Net Carrying Amount As of Stated Rate Effective Rate Principal Current Long-Term Total Principal Current Long-Term Total 2024 Term Loan A 3.700 % 3.74 % $ 1,188 $ — $ 1,187 $ 1,187 $ 1,188 $ — $ 1,186 $ 1,186 2026 Notes 4.975 % 5.07 % 500 — 498 498 500 — 498 498 2027 Notes (1) 4.185 % 4.27 % 900 — 806 806 900 — 901 901 2029 Notes 5.327 % 5.40 % 700 — 697 697 700 — 696 696 2030 Notes 4.663 % 4.73 % 850 — 846 846 850 — 846 846 2032 Green Bonds 2.703 % 2.77 % 1,000 — 994 994 — — — — 2041 Notes 3.366 % 3.41 % 500 — 496 496 — — — — 2051 Notes 3.477 % 3.52 % 500 — 496 496 — — — — Finance lease obligations N/A 2.65 % 886 103 783 886 804 155 649 804 2023 Notes N/A N/A — — — — 1,250 — 1,247 1,247 2024 Notes N/A N/A — — — — 600 — 598 598 $ 7,024 $ 103 $ 6,803 $ 6,906 $ 6,792 $ 155 $ 6,621 $ 6,776
Schedule of Debt Activity	The table below presents the effects of issuances and prepayments of debt in 2022: Increase (Decrease) in Principal Increase (Decrease) in Carrying Value Increase (Decrease) in Cash Gain (Loss) Issuances 2032 Green Bonds $ 1,000 $ 994 $ 994 $ — 2041 Notes 500 496 496 — 2051 Notes 500 496 496 — Prepayments 2023 Notes (1,250) (1,247) (1,281) (34) 2024 Notes (600) (598) (647) (49) $ 150 $ 141 $ 58 $ (83)
Schedule of Maturities of Notes Payable	As of September 1, 2022, maturities of notes payable by fiscal year were as follows: 2023 $ — 2024 — 2025 1,188 2026 500 2027 900 2028 and thereafter 3,550 Unamortized discounts (27) Hedge accounting fair value adjustment (91) $ 6,020

Equity (Tables)

Equity (Tables)	12 Months Ended
Equity (Tables)	Sep. 01, 2022
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss)	Gains (Losses) on Derivative Instruments Unrealized Gains (Losses) on Investments Pension Liability Adjustments Cumulative Foreign Currency Translation Adjustment Total As of September 2, 2021 $ (22) $ 1 $ 22 $ 1 $ 2 Other comprehensive income before reclassifications (720) (63) 6 (1) (778) Amount reclassified out of accumulated other comprehensive income 53 1 (2) — 52 Tax effects 151 14 (1) — 164 Other comprehensive income (loss) (516) (48) 3 (1) (562) As of September 1, 2022 $ (538) $ (47) $ 25 $ — $ (560)

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
Fair Value Measurements (Tables)	Sep. 01, 2022
Fair Value Disclosures [Abstract]
Estimated Fair Value and Carrying Value of Debt Instruments	2022 2021 As of Fair Carrying Fair Carrying Notes $ 5,472 $ 6,020 $ 6,584 $ 5,973

Derivative Instruments (Tables)

Derivative Instruments (Tables)	12 Months Ended
Derivative Instruments (Tables)	Sep. 01, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Derivative Instruments	Notional or Contractual Amount Fair Value of Assets (1) Liabilities (2) As of September 1, 2022 Derivative instruments with hedge accounting designation Cash flow currency hedges $ 5,427 $ — $ (330) Cash flow commodity hedges 97 1 (6) Fair value interest rate hedges 900 — (91) Derivative instruments without hedge accounting designation Non-designated currency hedges 2,821 7 (13) $ 8 $ (440) As of September 2, 2021 Derivative instruments with hedge accounting designation Cash flow currency hedges $ 3,601 $ 10 $ (66) Cash flow commodity hedges 45 2 — Fair value interest rate hedges 900 5 — Derivative instruments without hedge accounting designation Non-designated currency hedges 996 3 (2) $ 20 $ (68) (1) Included in receivables and other noncurrent assets. (2) Included in accounts payable and accrued expenses and other noncurrent liabilities.

Equity Plans (Tables)

Equity Plans (Tables)	12 Months Ended
Equity Plans (Tables)	Sep. 01, 2022
Share-Based Payment Arrangement [Abstract]
Schedule of Restricted Stock Awards Activity	Number of Shares Weighted-Average Grant Date Fair Value Per Share Outstanding as of September 2, 2021 20 $ 49.39 Granted 13 70.81 Restrictions lapsed (7) 47.36 Canceled (3) 57.00 Outstanding as of September 1, 2022 23 60.93 For the year ended 2022 2021 2020 Restricted stock award shares granted 13 11 8 Weighted-average grant-date fair value per share $ 70.81 $ 53.58 $ 46.44 Aggregate vesting-date fair value of shares vested $ 498 $ 385 $ 294
Employee Stock Purchase Plan Valuation Assumptions	For the year ended 2022 2021 2020 Weighted-average grant-date fair value per share $ 18.87 $ 20.71 $ 14.24 Average expected life in years 0.5 0.5 0.5 Weighted-average expected volatility (based on implied volatility) 43 % 41 % 45 % Weighted-average risk-free interest rate 2.0 % 0.1 % 0.8 % Expected dividend yield 0.6 % 0.3 % 0.0 %
Stock-based Compensation Expense	For the year ended 2022 2021 2020 Stock-based compensation expense by caption Cost of goods sold $ 193 $ 186 $ 139 Research and development 175 110 86 Selling, general, and administrative 133 99 103 Restructure (5) — — $ 496 $ 395 $ 328 Stock-based compensation expense by type of award Restricted stock awards $ 429 $ 333 $ 272 ESPP 66 52 39 Stock options 1 10 17 $ 496 $ 395 $ 328

Revenue (Tables)

Revenue (Tables)	12 Months Ended
Revenue (Tables)	Sep. 01, 2022
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	For the year ended 2022 2021 2020 DRAM $ 22,386 $ 20,039 $ 14,510 NAND 7,811 7,007 6,131 Other (primarily 3D XPoint memory and NOR) 561 659 794 $ 30,758 $ 27,705 $ 21,435

Restructure and Asset Impairm_2

Restructure and Asset Impairments (Tables)	12 Months Ended
Restructure and Asset Impairments (Tables)	Sep. 01, 2022
Restructuring and Related Activities [Abstract]
Restructure and Asset Impairments	For the year ended 2022 2021 2020 Restructure and asset impairments $ 48 $ 488 $ 60

Other Operating (Income) Expe_2

Other Operating (Income) Expense, Net (Tables)	12 Months Ended
Other Operating (Income) Expense, Net (Tables)	Sep. 01, 2022
Other Income and Expenses [Abstract]
Schedule of Other Operating (Income) Expense, Net	For the year ended 2022 2021 2020 Patent license charges $ — $ 128 $ — (Gain) loss on disposition of property, plant, and equipment (41) (24) (3) Other 7 (9) 11 $ (34) $ 95 $ 8

Other Non-Operating Income (E_2

Other Non-Operating Income (Expense), Net (Tables)	12 Months Ended
Other Non-Operating Income (Expense), Net (Tables)	Sep. 01, 2022
Other Nonoperating Income (Expense) [Abstract]
Schedule of Other Nonoperating Income (Expense), Net	For the year ended 2022 2021 2020 Gain (loss) on investments $ 26 $ 82 $ 22 Gain (loss) on debt prepayments, repurchases, and conversions (83) (1) 40 Other 19 — (2) $ (38) $ 81 $ 60

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
Income Taxes (Tables)	Sep. 01, 2022
Income Tax Disclosure [Abstract]
Schedule of Income (loss) Before Tax and Other Items	Our income tax (provision) benefit consisted of the following: For the year ended 2022 2021 2020 Income (loss) before income taxes, net income (loss) attributable to noncontrolling interests, and equity in net income (loss) of equity method investees U.S. $ 112 $ (211) $ 308 Foreign 9,459 6,429 2,675 $ 9,571 $ 6,218 $ 2,983 Income tax (provision) benefit Current U.S. federal $ (65) $ (42) $ (20) State (1) (1) (2) Foreign (528) (370) (148) (594) (413) (170) Deferred U.S. federal (166) (9) 39 State (225) 28 23 Foreign 97 — (172) (294) 19 (110) Income tax (provision) benefit $ (888) $ (394) $ (280)
Schedule of Components of Income Tax (Provision) Benefit	Our income tax (provision) benefit consisted of the following: For the year ended 2022 2021 2020 Income (loss) before income taxes, net income (loss) attributable to noncontrolling interests, and equity in net income (loss) of equity method investees U.S. $ 112 $ (211) $ 308 Foreign 9,459 6,429 2,675 $ 9,571 $ 6,218 $ 2,983 Income tax (provision) benefit Current U.S. federal $ (65) $ (42) $ (20) State (1) (1) (2) Foreign (528) (370) (148) (594) (413) (170) Deferred U.S. federal (166) (9) 39 State (225) 28 23 Foreign 97 — (172) (294) 19 (110) Income tax (provision) benefit $ (888) $ (394) $ (280)
Schedule of Effective Income Tax Reconciliation	The table below reconciles our tax (provision) benefit based on the U.S. federal statutory rate to our effective rate: For the year ended 2022 2021 2020 U.S. federal income tax (provision) benefit at statutory rate $ (2,010) 21.0 % $ (1,306) 21.0 % $ (626) 21.0 % U.S. tax on foreign operations (322) 3.4 % (226) 3.6 % (14) 0.5 % Change in valuation allowance (241) 2.5 % 54 (0.9) % (20) 0.7 % Change in unrecognized tax benefits (67) 0.7 % (238) 3.8 % (33) 1.1 % Foreign tax rate differential 1,601 (16.7) % 951 (15.3) % 253 (8.5) % Research and development tax credits 66 (0.7) % 123 (2.0) % 62 (2.1) % Foreign derived intangible income deduction 41 (0.4) % 18 (0.3) % 67 (2.2) % State taxes, net of federal benefit — — % 59 (0.9) % 23 (0.8) % Debt premium deductions — — % 130 (2.1) % — — % Other 44 (0.5) % 41 (0.6) % 8 (0.3) % Income tax (provision) benefit $ (888) 9.3 % $ (394) 6.3 % $ (280) 9.4 %
Schedule of Deferred Tax Assets and Liabilities	As of 2022 2021 Deferred tax assets Net operating loss and tax credit carryforwards $ 796 $ 783 Accrued salaries, wages, and benefits 157 206 Operating lease liabilities 138 109 Inventories 77 — Property, plant, and equipment 44 37 Other 142 115 Gross deferred tax assets 1,354 1,250 Less valuation allowance (471) (233) Deferred tax assets, net of valuation allowance 883 1,017 Deferred tax liabilities Right-of-use assets (126) (90) Product and process technology — (12) Other (68) (143) Deferred tax liabilities (194) (245) Net deferred tax assets $ 689 $ 772 Reported as Deferred tax assets $ 702 $ 782 Deferred tax liabilities (included in other noncurrent liabilities) (13) (10) Net deferred tax assets $ 689 $ 772
Schedule of Net Operating Loss Carryforwards	As of September 1, 2022, our net operating loss carryforward amounts and expiration periods, as reported to tax authorities, were as follows: Year of Expiration State Japan Malaysia Other Total 2023 - 2027 $ 44 $ 418 $ — $ 12 $ 474 2028 - 2032 377 234 — — 611 2033 - 2037 249 — — — 249 2038 - 2042 197 — — — 197 Indefinite 6 — 851 4 861 $ 873 $ 652 $ 851 $ 16 $ 2,392
Schedule of Tax Credit Carryforwards	As of September 1, 2022, our federal and state tax credit carryforward amounts and expiration periods, as reported to tax authorities, were as follows: Year of Tax Credit Expiration U.S. Federal State Total 2023 - 2027 $ — $ 46 $ 46 2028 - 2032 — 103 103 2033 - 2037 — 128 128 2038 - 2042 278 5 283 Indefinite — 115 115 $ 278 $ 397 $ 675
Schedule of Unrecognized Tax Benefits Rollforward	Below is a reconciliation of the beginning and ending amount of our unrecognized tax benefits: For the year ended 2022 2021 2020 Beginning unrecognized tax benefits $ 660 $ 411 $ 383 Increases related to tax positions from prior years 14 2 14 Increases related to tax positions taken in current year 80 260 27 Decreases related to tax positions from prior years (23) (13) (13) Ending unrecognized tax benefits $ 731 $ 660 $ 411

Earnings Per Share (Tables)

Earnings Per Share (Tables)	12 Months Ended
Earnings Per Share (Tables)	Sep. 01, 2022
Earnings Per Share [Abstract]
Basic and Diluted Earnings Per Share	For the year ended 2022 2021 2020 Net income attributable to Micron – Basic $ 8,687 $ 5,861 $ 2,687 Assumed conversion of debt — — (4) Net income attributable to Micron – Diluted $ 8,687 $ 5,861 $ 2,683 Weighted-average common shares outstanding – Basic 1,112 1,120 1,110 Dilutive effect of equity plans and convertible notes 10 21 21 Weighted-average common shares outstanding – Diluted 1,122 1,141 1,131 Earnings per share Basic $ 7.81 $ 5.23 $ 2.42 Diluted 7.75 5.14 2.37
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	Antidilutive potential common shares excluded from the computation of diluted earnings per share, that could dilute basic earnings per share in the future, were as follows at the end of the periods shown: For the year ended 2022 2021 2020 Equity plans 5 2 5

Segment and Other Information (

Segment and Other Information (Tables)	12 Months Ended
Segment and Other Information (Tables)	Sep. 01, 2022
Segment Reporting [Abstract]
Schedule of Results by Segment	For the year ended 2022 2021 2020 Revenue CNBU $ 13,693 $ 12,280 $ 9,184 MBU 7,260 7,203 5,702 EBU 5,235 4,209 2,759 SBU 4,553 3,973 3,765 All Other 17 40 25 $ 30,758 $ 27,705 $ 21,435 Operating income (loss) CNBU $ 5,844 $ 4,295 $ 2,010 MBU 2,160 2,173 1,074 EBU 1,752 1,006 301 SBU 513 173 36 All Other 12 20 (2) 10,281 7,667 3,419 Unallocated Stock-based compensation (501) (395) (328) Inventory accounting policy change to FIFO — (133) — Change in inventory cost absorption — (160) — 3D XPoint inventory write-down — (49) — Restructure and asset impairments (48) (488) (60) Patent license charges — (128) — Other (30) (31) (28) (579) (1,384) (416) Operating income $ 9,702 $ 6,283 $ 3,003 Depreciation and amortization expense included in operating income was as follows: For the year ended 2022 2021 2020 CNBU $ 2,766 $ 2,497 $ 2,318 MBU 1,725 1,553 1,436 EBU 1,280 1,028 741 SBU 1,323 1,101 1,115 All Other 2 8 12 Unallocated 20 27 28 $ 7,116 $ 6,214 $ 5,650

Certain Concentrations (Tables)

Certain Concentrations (Tables)	12 Months Ended
Certain Concentrations (Tables)	Sep. 01, 2022
Risks and Uncertainties [Abstract]
Schedule of Market Concentration Risk	For the year ended 2022 2021 2020 Mobile 25 % 25 % 25 % Client and graphics 20 % 20 % 20 % Enterprise and cloud server 20 % 20 % 20 % SSDs and other storage 15 % 15 % 20 % Automotive, industrial, and consumer 15 % 15 % 15 %

Geographic Information (Tables)

Geographic Information (Tables)	12 Months Ended
Geographic Information (Tables)	Sep. 01, 2022
Segment Reporting [Abstract]
Geographic Revenue from Contracts with Customers based on Location of Customer Headquarters	Revenue based on the geographic location of our customers’ headquarters was as follows: For the year ended 2022 2021 2020 United States $ 16,026 $ 12,155 $ 10,381 Taiwan 6,185 6,606 3,657 Mainland China (excluding Hong Kong) 3,311 2,456 2,337 Japan 1,696 1,652 1,387 Hong Kong 1,665 2,582 1,792 Other Asia Pacific 1,223 1,420 1,157 Other 652 834 724 $ 30,758 $ 27,705 $ 21,435
Long-lived Assets by Geographic Area	Long-lived assets by geographic area consisted of property, plant, and equipment and right-of-use assets and were as follows: As of 2022 2021 Taiwan $ 13,143 $ 11,457 Singapore 12,045 9,411 Japan 7,113 7,222 United States (1) 5,155 5,205 Malaysia 994 757 China 440 436 Other 337 175 $ 39,227 $ 34,663 (1) Included $899 million (net of impairment) as of September 2, 2021 of property, plant, and equipment for our Lehi facility that was classified as held for sale and presented in other current assets.

Schedule II Valuation and Qua_2

Schedule II Valuation and Qualifying Accounts (Tables)	12 Months Ended
Schedule II Valuation and Qualifying Accounts (Tables)	Sep. 01, 2022
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]
Deferred Tax Asset Valuation Allowance	Balance at Charged Currency Balance at Deferred Tax Asset Valuation Allowance Year ended September 1, 2022 $ 233 $ 241 $ (3) $ 471 Year ended September 2, 2021 294 (54) (7) 233 Year ended September 3, 2020 277 20 (3) 294

Significant Accounting Polici_3

Significant Accounting Policies - Inventories (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Mar. 04, 2021	Sep. 01, 2022	Sep. 02, 2021	Sep. 03, 2020
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Inventories		$ 6,663	$ 4,487
Cost of goods sold		$ 16,860	$ 17,282	$ 14,883
Change in Accounting Principle, Inventory Method
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Inventories	$ (133)
Cost of goods sold	$ 133

Significant Accounting Polici_4

Significant Accounting Policies - Product and Process Technology (Details)	12 Months Ended
	Sep. 01, 2022
Maximum
Finite-Lived Intangible Assets [Line Items]
Maximum life of product and process technology intangible assets (in years)	12 years 6 months

Significant Accounting Polici_5

Significant Accounting Policies - Property, Plant and Equipment (Details)	12 Months Ended
	Sep. 01, 2022
Buildings \| Minimum
Property, Plant and Equipment [Line Items]
Property, plant, and equipment useful life (in years)	10 years
Buildings \| Maximum
Property, Plant and Equipment [Line Items]
Property, plant, and equipment useful life (in years)	30 years
Equipment \| Minimum
Property, Plant and Equipment [Line Items]
Property, plant, and equipment useful life (in years)	5 years
Equipment \| Maximum
Property, Plant and Equipment [Line Items]
Property, plant, and equipment useful life (in years)	7 years
Software \| Minimum
Property, Plant and Equipment [Line Items]
Property, plant, and equipment useful life (in years)	3 years
Software \| Maximum
Property, Plant and Equipment [Line Items]
Property, plant, and equipment useful life (in years)	5 years

Lehi, Utah Fab and 3D XPoint (D

Lehi, Utah Fab and 3D XPoint (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Dec. 02, 2021	Sep. 02, 2021	Oct. 22, 2021
3D XPoint
Other Income Statement Impacts related to Lehi Disposal
3D XPoint inventory write-down		$ 49
Lehi, Utah Facility
Disposal Activities
Consideration for Lehi, UT facility			$ 893
Lehi net assets disposed of			918
Lehi property, plant, and equipment disposed of			921
Lehi other assets disposed of			55
Lehi liabilities disposed of (primarily finance lease obligation)			$ (58)
Loss on Lehi disposal	$ 23
Loss on Lehi disposal, income statement location	Restructure and asset impairments
Other Income Statement Impacts related to Lehi Disposal
Lehi held for sale write-down		435
Tax benefit from write-down of Lehi assets		104
Lehi Disposal Group Held for Sale
Property, plant, and equipment		1,334
Other current assets		50
Impairment		(435)
Lehi assets held for sale		949
Lehi Finance Lease Liabilities		50
Other Lehi liabilities		$ 11

Variable Interest Entities (Det

Variable Interest Entities (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Nov. 28, 2019	Sep. 01, 2022	Sep. 02, 2021	Sep. 03, 2020
Acquisition of Noncontrolling Interest in IMFT
Acquisition of noncontrolling interest in IMFT		$ 0	$ 0	$ 744
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interest				784
Revenue		$ 30,758	$ 27,705	21,435
Noncontrolling Interests in Subsidiaries
Acquisition of Noncontrolling Interest in IMFT
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interest				$ 904
Intel \| IM Flash Technologies, LLC
Acquisition of Noncontrolling Interest in IMFT
Revenue	$ 158
IM Flash Technologies, LLC
Acquisition of Noncontrolling Interest in IMFT
Payments to Noncontrolling Interests, Purchase of Minority Interest and Repayment of Debt	1,250
Decrease in Noncontrolling Interest from Purchase of Interests in IMFT, Effect on APIC Before Tax	160
Acquisition of noncontrolling interest in IMFT	744
IM Flash Technologies, LLC \| Noncontrolling Interests in Subsidiaries
Acquisition of Noncontrolling Interest in IMFT
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interest	$ 904

Cash and Investments (Details)

Cash and Investments (Details) - USD ($) $ in Millions		Sep. 01, 2022	Sep. 02, 2021	Sep. 03, 2020	Aug. 29, 2019
Debt Securities, Available-for-sale [Line Items]
Cash and Equivalents		$ 8,262	$ 7,763
Short-term Investments		1,069	870
Long-term Marketable Investments	[1]	1,647	1,765
Total Fair Value		10,978	10,398
Restricted cash	[2]	77	66
Cash, cash equivalents, and restricted cash		$ 8,339	7,829	$ 7,690	$ 7,279
Minimum
Debt Securities, Available-for-sale [Line Items]
Debt Securities, Available-for-sale, Term, Noncurrent		1 year
Maximum
Debt Securities, Available-for-sale [Line Items]
Debt Securities, Available-for-sale, Term, Noncurrent		4 years
Cash
Debt Securities, Available-for-sale [Line Items]
Cash and Equivalents		$ 6,055	5,796
Short-term Investments		0	0
Long-term Marketable Investments		0	0
Total Fair Value		6,055	5,796
Money market funds \| Level 1
Debt Securities, Available-for-sale [Line Items]
Cash and Equivalents	[3]	1,196	38
Short-term Investments	[3]	0	0
Long-term Marketable Investments	[1],[3]	0	0
Total Fair Value	[3]	1,196	38
Certificates of deposits \| Level 2
Debt Securities, Available-for-sale [Line Items]
Cash and Equivalents	[4]	976	1,907
Short-term Investments	[4]	50	69
Long-term Marketable Investments	[1],[4]	0	0
Total Fair Value	[4]	1,026	1,976
Corporate bonds \| Level 2
Debt Securities, Available-for-sale [Line Items]
Cash and Equivalents	[4]	0	9
Short-term Investments	[4]	759	429
Long-term Marketable Investments	[1],[4]	995	1,134
Total Fair Value	[4]	1,754	1,572
Asset-backed securities \| Level 2
Debt Securities, Available-for-sale [Line Items]
Cash and Equivalents	[4]	0	8
Short-term Investments	[4]	20	95
Long-term Marketable Investments	[1],[4]	608	509
Total Fair Value	[4]	628	612
Government securities \| Level 2
Debt Securities, Available-for-sale [Line Items]
Cash and Equivalents	[4]	2	1
Short-term Investments	[4]	155	190
Long-term Marketable Investments	[1],[4]	44	122
Total Fair Value	[4]	201	313
Commercial paper \| Level 2
Debt Securities, Available-for-sale [Line Items]
Cash and Equivalents	[4]	33	4
Short-term Investments	[4]	85	87
Long-term Marketable Investments	[1],[4]	0	0
Total Fair Value	[4]	$ 118	$ 91

[1] The maturities of long-term marketable securities primarily range from one four years.

Cash and Investments - Non-mark

Cash and Investments - Non-marketable Equity Investments (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 01, 2022	Sep. 02, 2021
Equity Securities, FV-NI and without Readily Determinable Fair Value [Abstract]
Equity Securities without Readily Determinable Fair Value, Amount	$ 222	$ 153
Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount	$ 36	$ 70

Receivables (Details)

Receivables (Details) - USD ($) $ in Millions	Sep. 01, 2022	Sep. 02, 2021
Receivables [Abstract]
Trade receivables	$ 4,765	$ 4,920
Income and other taxes	251	264
Other	114	127
Receivables	$ 5,130	$ 5,311

Inventories (Details)

Inventories (Details) - USD ($) $ in Millions	Sep. 01, 2022	Sep. 02, 2021
Inventory, Net, Items Net of Reserve Alternative [Abstract]
Finished goods	$ 1,028	$ 513
Work in process	4,830	3,469
Raw materials and supplies	805	505
Inventories	$ 6,663	$ 4,487

Inventories - Change to FIFO (D

Inventories - Change to FIFO (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended	12 Months Ended
	Mar. 04, 2021	Sep. 01, 2022	Sep. 02, 2021	Sep. 03, 2020
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Inventories		$ 6,663	$ 4,487
Cost of goods sold		16,860	17,282	$ 14,883
Net income		$ 8,687	$ 5,861	$ 2,687
Diluted (in dollars per share)		$ 7.75	$ 5.14	$ 2.37
Change in Accounting Principle, Inventory Method
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Inventories	$ (133)
Cost of goods sold	133
Net income	$ (128)		$ (128)
Diluted (in dollars per share)	$ (0.11)		$ (0.11)

Property, Plant, and Equipmen_2

Property, Plant, and Equipment (Details) - USD ($) $ in Millions		12 Months Ended
		Sep. 01, 2022	Sep. 02, 2021	Sep. 03, 2020
Property, Plant, and Equipment including Finance Lease Right-of-Use Asset
Property, plant, and equipment, gross		$ 81,331	$ 69,462
Accumulated depreciation		(42,782)	(36,249)
Property, plant, and equipment, net		38,549	33,213
Depreciation
Depreciation expense		7,030	6,130	$ 5,570
Capitalized Interest
Interest capitalized as part of the cost of property, plant, and equipment		77	66	$ 77
Land
Property, Plant, and Equipment including Finance Lease Right-of-Use Asset
Property, plant, and equipment, gross		280	280
Buildings
Property, Plant, and Equipment including Finance Lease Right-of-Use Asset
Property, plant, and equipment, gross		16,676	14,776
Equipment
Property, Plant, and Equipment including Finance Lease Right-of-Use Asset
Property, plant, and equipment, gross	[1]	61,354	51,902
Equipment not placed into service
Property, Plant, and Equipment including Finance Lease Right-of-Use Asset
Property, plant, and equipment, gross		3,350	1,990
Construction in progress
Property, Plant, and Equipment including Finance Lease Right-of-Use Asset
Property, plant, and equipment, gross	[2]	1,897	1,517
Software
Property, Plant, and Equipment including Finance Lease Right-of-Use Asset
Property, plant, and equipment, gross		$ 1,124	$ 987

[1]Includes costs related to equipment not placed into service of $3.35 billion as of September 1, 2022 and $1.99 billion as of September 2, 2021.[2]Includes building-related construction, tool installation, and software costs for assets not placed into service.

Intangible Assets and Goodwil_2

Intangible Assets and Goodwill (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 01, 2022	Sep. 02, 2021	Sep. 03, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Gross Amount, Product and process technology	$ 742	$ 633
Accumulated Amortization, Product and process technology	(321)	(284)
Goodwill	1,228	1,228
Amortizing assets [Line Items]
Increase in product and process technology	158	106	$ 73
Amortization [Abstract]
Amortization of Intangible Assets	85	$ 82	$ 78
Annual amortization expense for intangible assets [Abstract]
2023	83
2024	72
2025	52
2026	43
2027	$ 37
Weighted Average
Amortizing assets [Line Items]
Useful lives of assets placed into service	9 years	9 years	10 years

Leases - Cost and Cash Flows (D

Leases - Cost and Cash Flows (Details) - USD ($) $ in Millions		12 Months Ended
		Sep. 01, 2022	Sep. 02, 2021	Sep. 03, 2020
Components of Lease Expense
Amortization of right-of-use asset		$ 99	$ 69	$ 140
Interest on lease liability		24	20	22
Operating lease cost(1)	[1]	125	108	102
Total lease cost		248	197	264
Cash flows used for operating activities
Finance leases		23	21	24
Operating leases		110	106	39	[2]
Cash flows used for financing activities
Cash flows used for financing activities – Finance leases		103	85	248
Finance leases, noncash acquisitions of right-of-use assets		309	395	107
Operating leases, noncash acquisitions of right-of-use assets		$ 197	$ 27	11
Proceeds from tenant allowance				$ 48
Lessee, Finance Lease Description
Finance Lease Right-of-Use Asset, Balance Sheet Location		Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization	Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization
Finance lease right-of-use assets (included in property, plant, and equipment and assets held for sale)		$ 904	$ 766
Finance leases, Weighted-average remaining lease term (in years)		12 years	11 years
Finance leases, Weighted-average discount rate		2.65%	3.14%
Lessee, Operating Lease Description
Operating Lease Liability, Balance Sheet Location		Accounts payable and accrued expenses	Accounts payable and accrued expenses
Current operating lease liabilities (included in accounts payable and accrued expenses)		$ 60	$ 55
Operating leases, Weighted-average remaining lease term (in years)		12 years	12 years
Operating leases, Weighted-average discount rate		2.90%	2.63%
Real Estate \| Minimum
Lessee, Lease, Description [Line Items]
Operating lease renewal term		1 year
Real Estate \| Maximum
Lessee, Lease, Description [Line Items]
Operating lease renewal term		10 years
Land \| Minimum
Lessee, Lease, Description [Line Items]
Operating lease renewal term		1 year
Land \| Maximum
Lessee, Lease, Description [Line Items]
Operating lease renewal term		30 years

[1]Operating lease cost includes short-term and variable lease expenses, which were not material for the periods presented.[2]Includes $48 million of reimbursements received for tenant improvements for 2020.

Leases - Maturities (Details)

Leases - Maturities (Details) - USD ($) $ in Millions	Sep. 01, 2022	Sep. 02, 2021
Finance Lease Maturities
2023	$ 123
2024	100
2025	87
2026	87
2027	86
2028 and thereafter	534
Less imputed interest	(131)
Finance Lease Liability	886	$ 804
Operating Lease Maturities
2023	66
2024	80
2025	70
2026	67
2027	64
2028 and thereafter	463
Less imputed interest	(140)
Operating Lease Liability	$ 670

Leases - Not Yet Commenced (Det

Leases - Not Yet Commenced (Details) $ in Millions	Sep. 01, 2022 USD ($)
Finance Lease Not yet Commenced
Payment obligations	$ 212
Weighted Average
Finance Lease Not yet Commenced
Lease term	14 years

Accounts Payable and Accrued _3

Accounts Payable and Accrued Expenses (Details) - USD ($) $ in Millions	Sep. 01, 2022	Sep. 02, 2021
Accounts Payable and Accrued Liabilities, Current [Abstract]
Accounts payable	$ 2,142	$ 1,744
Property, plant, and equipment	2,170	1,887
Salaries, wages, and benefits	877	984
Income and other taxes	420	364
Other	481	346
Total accounts payable and accrued expenses	$ 6,090	$ 5,325

Debt - Long-term Debt (Details)

Debt - Long-term Debt (Details) - USD ($)			12 Months Ended
Debt - Long-term Debt (Details) - USD ($)		Nov. 01, 2021	Sep. 01, 2022	Sep. 02, 2021	Sep. 03, 2020
Long-term Debt by Current and Noncurrent
Total Long-term Debt			$ 6,020,000,000
Finance Lease Effective Rate (in ten thousandths)			2.65%	3.14%
Current Finance Lease Obligations			$ 103,000,000	$ 155,000,000
Long-Term Finance Lease Obligations			783,000,000	649,000,000
Total Finance Lease Obligations			886,000,000	804,000,000
Long-term Debt and Lease Obligation
Principal (including finance lease obligation)			7,024,000,000	6,792,000,000
Current debt (including finance lease obligation)			103,000,000	155,000,000
Long-term debt (including finance lease obligation)			6,803,000,000	6,621,000,000
Total Net Carrying Amount of Debt (including finance lease obligation)			$ 6,906,000,000	$ 6,776,000,000
Current finance lease liability, statement of financial position			Current debt (including finance lease obligation)	Current debt (including finance lease obligation)
Noncurrent finance lease liability, statement of financial position			Long-term debt (including finance lease obligation)	Long-term debt (including finance lease obligation)
Senior Unsecured Notes
Increase (Decrease) Principal			$ 150,000,000
2024 Term Loans
Proceeds from issuance of debt			2,000,000,000	$ 1,188,000,000	$ 5,000,000,000
Repayments of Debt					$ 3,920,000,000
Maturities of Notes Payable
2023			0
2024			0
2025			1,188,000,000
2026			500,000,000
2027			900,000,000
2028 and thereafter			3,550,000,000
Unamortized discounts			(27,000,000)
Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease)			(91,000,000)
Long-term Debt			6,020,000,000
Interest rate swap \| Fair value hedges \| Designated hedging instruments
Long-term Debt and Lease Obligation
Notional or Contractual Amount			900,000,000	900,000,000
Micron Technology, Inc.
Long-term Debt and Lease Obligation
Subordinated Debt			$ 6,020,000,000
SOFR \| Interest rate swap \| Fair value hedges \| Designated hedging instruments
Long-term Debt and Lease Obligation
Spread on 2027 Variable Interest Rate			3.33%
Extinguished 2024 Term Loan A \| Term Loan
2024 Term Loans
Repayments of Debt				1,190,000,000
Term Loan \| 2024 Term Loan A
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)			3.70%
Effective Rate (in ten thousandths)			3.74%
Principal			$ 1,188,000,000	1,188,000,000
Current Portion of Long-term Debt			0	0
Noncurrent Long-Term Debt			1,187,000,000	1,186,000,000
Total Long-term Debt			1,187,000,000	1,186,000,000
2024 Term Loans
Proceeds from issuance of debt				1,190,000,000
Maturities of Notes Payable
Long-term Debt			$ 1,187,000,000	1,186,000,000
Term Loan \| 2024 Term Loan A \| LIBOR \| Minimum
Revolving Credit Facility
Margin on variable rate financing			0.625%
Term Loan \| 2024 Term Loan A \| LIBOR \| Maximum
Revolving Credit Facility
Margin on variable rate financing			1.375%
Corporate Bonds
Senior Unsecured Notes
Increase (Decrease) Principal		$ 2,000,000,000
Debt Issuance Costs		$ 14,000,000
Redemption price percentage upon change in control			100%
Debt Covenant, Restricted Subsidiaries, Ownership Percentage by Parent (in hundredths)			80%
Debt Instrument, Redemption Price Percentage, Change in Control Event			101%
Corporate Bonds \| 2026 Notes
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)			4.975%
Effective Rate (in ten thousandths)			5.07%
Principal			$ 500,000,000	500,000,000
Current Portion of Long-term Debt			0	0
Noncurrent Long-Term Debt			498,000,000	498,000,000
Total Long-term Debt			498,000,000	498,000,000
Maturities of Notes Payable
Long-term Debt			$ 498,000,000	498,000,000
Corporate Bonds \| 2027 Notes
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)	[1]		4.185%
Effective Rate (in ten thousandths)	[1]		4.27%
Principal			$ 900,000,000	900,000,000
Current Portion of Long-term Debt	[1]		0	0
Noncurrent Long-Term Debt	[1]		806,000,000	901,000,000
Total Long-term Debt	[1]		806,000,000	901,000,000
Maturities of Notes Payable
Long-term Debt	[1]		$ 806,000,000	901,000,000
Corporate Bonds \| 2029 Notes
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)			5.327%
Effective Rate (in ten thousandths)			5.40%
Principal			$ 700,000,000	700,000,000
Current Portion of Long-term Debt			0	0
Noncurrent Long-Term Debt			697,000,000	696,000,000
Total Long-term Debt			697,000,000	696,000,000
Maturities of Notes Payable
Long-term Debt			$ 697,000,000	696,000,000
Corporate Bonds \| 2030 Notes
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)			4.663%
Effective Rate (in ten thousandths)			4.73%
Principal			$ 850,000,000	850,000,000
Current Portion of Long-term Debt			0	0
Noncurrent Long-Term Debt			846,000,000	846,000,000
Total Long-term Debt			846,000,000	846,000,000
Maturities of Notes Payable
Long-term Debt			$ 846,000,000	846,000,000
Corporate Bonds \| Unsecured Senior Corporate Green Bond Due 2032
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)			2.703%
Effective Rate (in ten thousandths)			2.77%
Principal			$ 1,000,000,000	0
Current Portion of Long-term Debt			0	0
Noncurrent Long-Term Debt			994,000,000	0
Total Long-term Debt			994,000,000	0
Senior Unsecured Notes
Increase (Decrease) Principal			1,000,000,000
Maturities of Notes Payable
Long-term Debt			$ 994,000,000	0
Corporate Bonds \| 2041 Notes
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)			3.366%
Effective Rate (in ten thousandths)			3.41%
Principal			$ 500,000,000	0
Current Portion of Long-term Debt			0	0
Noncurrent Long-Term Debt			496,000,000	0
Total Long-term Debt			496,000,000	0
Senior Unsecured Notes
Increase (Decrease) Principal			500,000,000
Maturities of Notes Payable
Long-term Debt			$ 496,000,000	0
Corporate Bonds \| 2051 Notes
Long-term Debt by Current and Noncurrent
Stated Rate (exact percentage)			3.477%
Effective Rate (in ten thousandths)			3.52%
Principal			$ 500,000,000	0
Current Portion of Long-term Debt			0	0
Noncurrent Long-Term Debt			496,000,000	0
Total Long-term Debt			496,000,000	0
Senior Unsecured Notes
Increase (Decrease) Principal			500,000,000
Maturities of Notes Payable
Long-term Debt			496,000,000	0
Corporate Bonds \| 2023 Notes
Long-term Debt by Current and Noncurrent
Principal			0	1,250,000,000
Current Portion of Long-term Debt			0	0
Noncurrent Long-Term Debt			0	1,247,000,000
Total Long-term Debt			0	1,247,000,000
Maturities of Notes Payable
Long-term Debt			0	1,247,000,000
Corporate Bonds \| 2024 Notes
Long-term Debt by Current and Noncurrent
Principal			0	600,000,000
Current Portion of Long-term Debt			0	0
Noncurrent Long-Term Debt			0	598,000,000
Total Long-term Debt			0	598,000,000
Maturities of Notes Payable
Long-term Debt			0	$ 598,000,000
Revolving Credit Facility \| 2026 Revolving Credit Facility
Long-term Debt by Current and Noncurrent
Total Long-term Debt			$ 0
Revolving Credit Facility
Debt term (in years)			5 years
Maximum Borrowing Capacity			$ 2,500,000,000
Available borrowing capacity			2,500,000,000
Maturities of Notes Payable
Long-term Debt			$ 0
Revolving Credit Facility \| 2026 Revolving Credit Facility \| Maximum
Revolving Credit Facility
Debt Covenant, Ratio Of Total Debt To Adjusted EBITDA			3.25
Revolving Credit Facility \| 2026 Revolving Credit Facility \| LIBOR \| Minimum
Revolving Credit Facility
Margin on variable rate financing			1%
Revolving Credit Facility \| 2026 Revolving Credit Facility \| LIBOR \| Maximum
Revolving Credit Facility
Margin on variable rate financing			1.75%

[1]In 2021, we entered into fixed-to-floating interest rate swaps on the 2027 Notes with an aggregate $900 million notional amount equal to the principal amount of the 2027 Notes. The resulting variable interest paid is at a rate equal to SOFR plus approximately 3.33%. The fixed-to-floating interest rate swaps are accounted for as fair value hedges, as a result, the carrying values of our 2027 Notes reflect adjustments in fair value.

Debt - Debt Activity (Details)

Debt - Debt Activity (Details) - USD ($) shares in Millions, $ in Millions		12 Months Ended
	Nov. 01, 2021	Sep. 01, 2022	Sep. 02, 2021	Sep. 03, 2020
Extinguishment of Debt [Line Items]
Increase (Decrease) Principal		$ 150
Increase (Decrease) in Carrying Value		141		$ (3,900)
Gain (loss) on debt prepayments, repurchases, and conversions		(83)	$ (1)	40
Increase (Decrease) in Cash From Certain Debt Activities, Net		58
Extinguishment of Debt, Amount				(3,770)
(Decrease) in Cash - Prepayments and Conversions				$ (3,920)
Convertible Debt \| 2032D Notes
Extinguishment of Debt [Line Items]
Stock issued for convertible notes (shares)			11.1
(Decrease) in Cash - Prepayments and Conversions			$ (185)
Corporate Bonds \| 2023 Notes
Extinguishment of Debt [Line Items]
Increase (Decrease) in Carrying Value		(1,247)
Gain (loss) on debt prepayments, repurchases, and conversions		(34)
Extinguishment of Debt, Amount		(1,250)
(Decrease) in Cash - Prepayments and Conversions		(1,281)
Corporate Bonds \| 2024 Notes
Extinguishment of Debt [Line Items]
Increase (Decrease) in Carrying Value		(598)
Gain (loss) on debt prepayments, repurchases, and conversions		(49)
Extinguishment of Debt, Amount		(600)
(Decrease) in Cash - Prepayments and Conversions		(647)
Corporate Bonds
Extinguishment of Debt [Line Items]
Increase (Decrease) Principal	$ 2,000
Corporate Bonds \| Unsecured Senior Corporate Green Bond Due 2032
Extinguishment of Debt [Line Items]
Increase in Cash - Issuances		994
Increase (Decrease) Principal		1,000
Increase (Decrease) in Carrying Value		994
Corporate Bonds \| 2041 Notes
Extinguishment of Debt [Line Items]
Increase in Cash - Issuances		496
Increase (Decrease) Principal		500
Increase (Decrease) in Carrying Value		496
Corporate Bonds \| 2051 Notes
Extinguishment of Debt [Line Items]
Increase in Cash - Issuances		496
Increase (Decrease) Principal		500
Increase (Decrease) in Carrying Value		$ 496

Commitments (Details)

Commitments (Details) $ in Billions	Sep. 01, 2022 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Commitments for purchase obligations	$ 7.1
Commitments for purchase obligations, portion due within one year	$ 5.4

Contingencies (Details)

Contingencies (Details) ¥ in Millions, $ in Millions			12 Months Ended
Contingencies (Details) ¥ in Millions, $ in Millions	Oct. 05, 2022 patent	Sep. 30, 2022 patent	Sep. 01, 2022 CNY (¥) patent complaint	Sep. 01, 2022 USD ($) patent complaint	Oct. 06, 2022 complaint
Securities Matters \| Pending Litigation
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number \| complaint			2	2
Innovative Memory Solutions, Inc. vs Micron-Complaint 1 \| Patent Matters
Loss Contingencies [Line Items]
Number of patents allegedly infringed			8	8
Loss Contingency, Patents Found Not Infringed, Number			6	6
Innovative Memory Solutions, Inc. vs Micron-Complaint 1 \| Patent Matters \| Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed			2	2
Fujian Jinhua Integrated Circuit Co., Ltd. vs Micron-Complaint 1 \| Patent Matters \| Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed			1	1
Damages sought on alleged patent infringement \| ¥			¥ 98
Fujian Jinhua Integrated Circuit Co., Ltd. vs Micron-Complaint 2 \| Patent Matters \| Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed			1	1
Damages sought on alleged patent infringement \| ¥			¥ 98
United Microelectronics Corporation vs Micron-Complaint 1 \| Patent Matters \| Withdrawn Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed			1	1
Damages sought on alleged patent infringement \| ¥			¥ 90
United Microelectronics Corporation vs Micron-Complaint 2 \| Patent Matters \| Withdrawn Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed			1	1
Damages sought on alleged patent infringement \| ¥			¥ 90
Flash-Control, LLC vs Micron \| Patent Matters
Loss Contingencies [Line Items]
Number of patents allegedly infringed			4	4
Loss Contingency, Patents Found Not Infringed, Number			2	2
Netlist Inc. vs Micron \| Patent Matters \| Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed			1	1
Netlist Inc vs Micron - Complaint 2 \| Patent Matters \| Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed			3	3
Netlist Inc. vs Micron - Complaint 3 \| Patent Matters \| Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed			2	2
Netlist Inc. vs Micron - Complaint 4 \| Patent Matters \| Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed			6	6
Netlist Inc. vs Micron - Complaint 5 \| Patent Matters \| Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed			1	1
Netlist Inc. vs Micron - Complaint 5 Amendment \| Patent Matters \| Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed			2	2
Vervain LLC vs Micron \| Patent Matters \| Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed			4	4
Bell Semiconductor LLC vs Micron \| Patent Matters \| Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed			1	1
Bell Semiconductor LLC vs Micron - Complaint 2 \| Patent Matters \| Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed			2	2
Bell Semiconductor LLC vs Micron - Complaint 3 \| Patent Matters \| Pending Litigation \| Subsequent Event
Loss Contingencies [Line Items]
Number of patents allegedly infringed		6
Bell Semiconductor LLC vs Micron - Complaint 4 \| Patent Matters \| Pending Litigation \| Subsequent Event
Loss Contingencies [Line Items]
Number of patents allegedly infringed	1
Bell Semiconductor LLC vs Micron and Others - ITC \| Patent Matters \| Pending Litigation \| Subsequent Event
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number \| complaint					1
Sonrai Memory, Ltd. vs Micron \| Patent Matters \| Pending Litigation
Loss Contingencies [Line Items]
Number of patents allegedly infringed			2	2
Qimonda AG Inotera Share Purchase Proceedings \| Under Appeal
Loss Contingencies [Line Items]
Percentage of total Inotera shares subject to litigation (in hundredths)			18%	18%
Loss contingency, judgment under appeal \| $				$ 1
Subsequent indirect DRAM Purchasers United States vs Micron \| Antitrust Matters \| Dismissed Litigation
Loss Contingencies [Line Items]
Loss Contingency, Claims Dismissed, Number \| complaint			2	2
Subsequent direct DRAM Purchasers United States vs Micron \| Antitrust Matters \| Dismissed Litigation
Loss Contingencies [Line Items]
Loss Contingency, Claims Dismissed, Number \| complaint			4	4
DRAM Purchasers Canada vs Micron \| Antitrust Matters \| Pending Litigation
Loss Contingencies [Line Items]
Loss Contingency, Pending Claims, Number \| complaint			6	6

Equity - Common Stock Repurchas

Equity - Common Stock Repurchases and Dividends (Details) - USD ($) $ / shares in Units, shares in Millions		12 Months Ended			48 Months Ended
	Sep. 29, 2022	Sep. 01, 2022	Sep. 02, 2021	Sep. 03, 2020	Sep. 01, 2022
Common Stock Repurchases
Payments for Repurchase of Common Stock		$ 2,432,000,000	$ 1,200,000,000	$ 176,000,000
Dividends
Cash dividends declared (per share)		$ 0.315	$ 0.10
Subsequent Event
Dividends
Cash dividends declared (per share)	$ 0.115
Dividends Payable, Date to be Paid	Oct. 26, 2022
Dividends Payable, Date of Record	Oct. 11, 2022
Repurchases Authorized by the BOD
Common Stock Repurchases
Common Stock Repurchase, Authorized Amount		$ 10,000,000,000			$ 10,000,000,000
Treasury Shares Repurchased (in shares)		35.4	15.6
Payments for Repurchase of Common Stock		$ 2,430,000,000	$ 1,200,000,000		$ 6,470,000,000

Equity - Accumulated Other Comp

Equity - Accumulated Other Comprehensive Income (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 01, 2022	Sep. 02, 2021	Sep. 03, 2020
Accumulated Other Comprehensive Income (Loss)
Accumulated other comprehensive income (loss)	$ 2
Other comprehensive income before reclassifications	(778)
Amount reclassified out of accumulated other comprehensive income	52
Tax effects	164
Other comprehensive income (loss)	(562)	$ (69)	$ 62
Accumulated other comprehensive income (loss)	(560)	2
Gains (Losses) on Derivative Instruments
Accumulated Other Comprehensive Income (Loss)
Accumulated other comprehensive income (loss)	(22)
Other comprehensive income before reclassifications	(720)
Amount reclassified out of accumulated other comprehensive income	53
Tax effects	151
Other comprehensive income (loss)	(516)
Accumulated other comprehensive income (loss)	(538)	(22)
Unrealized Gains (Losses) on Investments
Accumulated Other Comprehensive Income (Loss)
Accumulated other comprehensive income (loss)	1
Other comprehensive income before reclassifications	(63)
Amount reclassified out of accumulated other comprehensive income	1
Tax effects	14
Other comprehensive income (loss)	(48)
Accumulated other comprehensive income (loss)	(47)	1
Pension Liability Adjustments
Accumulated Other Comprehensive Income (Loss)
Accumulated other comprehensive income (loss)	22
Other comprehensive income before reclassifications	6
Amount reclassified out of accumulated other comprehensive income	(2)
Tax effects	(1)
Other comprehensive income (loss)	3
Accumulated other comprehensive income (loss)	25	22
Cumulative Foreign Currency Translation Adjustment
Accumulated Other Comprehensive Income (Loss)
Accumulated other comprehensive income (loss)	1
Other comprehensive income before reclassifications	(1)
Amount reclassified out of accumulated other comprehensive income	0
Tax effects	0
Other comprehensive income (loss)	(1)
Accumulated other comprehensive income (loss)	$ 0	$ 1

Fair Value Measurements - Fair

Fair Value Measurements - Fair and Carrying Value of Debt (Details) - USD ($) $ in Millions	Sep. 01, 2022	Sep. 02, 2021
Fair Value
Fair Value of Notes Payable
Notes (level 2)	$ 5,472	$ 6,584
Carrying Value
Fair Value of Notes Payable
Notes (level 2)	$ 6,020	$ 5,973

Derivative Instruments - Notion

Derivative Instruments - Notional Amounts and Fair Values (Details) - USD ($) $ in Millions		12 Months Ended
		Sep. 01, 2022	Sep. 02, 2021
Fair Value of Derivative Assets and Liabilities
Fair Value of Assets	[1]	$ 8	$ 20
Fair Value of Liabilities	[2]	$ (440)	(68)
Designated hedging instruments \| Cash flow hedges
Fair Value of Derivative Assets and Liabilities
General maturity of cash flow hedges (in years)		2 years
Designated hedging instruments \| Cash flow hedges \| Currency hedges
Notional Disclosures
Notional or Contractual Amount		$ 5,427	3,601
Fair Value of Derivative Assets and Liabilities
Fair Value of Assets	[1]	0	10
Fair Value of Liabilities	[2]	(330)	(66)
Designated hedging instruments \| Cash flow hedges \| Commodity hedges
Notional Disclosures
Notional or Contractual Amount		97	45
Fair Value of Derivative Assets and Liabilities
Fair Value of Assets	[1]	1	2
Fair Value of Liabilities	[2]	(6)	0
Designated hedging instruments \| Fair value hedges \| Interest rate swap
Notional Disclosures
Notional or Contractual Amount		900	900
Fair Value of Derivative Assets and Liabilities
Fair Value of Assets	[1]	0	5
Fair Value of Liabilities	[2]	(91)	0
Not designated hedging instruments \| Currency hedges
Notional Disclosures
Notional or Contractual Amount		2,821	996
Fair Value of Derivative Assets and Liabilities
Fair Value of Assets	[1]	7	3
Fair Value of Liabilities	[2]	$ (13)	$ (2)
General maturity of currency forward contracts (in months)		3 months

[1]Included in receivables and other noncurrent assets.[2]Included in accounts payable and accrued expenses and other noncurrent liabilities.

Derivative Instruments - Gain (

Derivative Instruments - Gain (Loss) on Derivatives (Details) - Designated hedging instruments - USD ($) $ in Millions	12 Months Ended
	Sep. 01, 2022	Sep. 02, 2021	Sep. 03, 2020
Cash flow hedges
Derivative Instruments, Gain (Loss) [Line Items]
Net gains (losses) recognized in other comprehensive income from cash flow hedges	$ (735)	$ (52)	$ 51
Cash flow hedge gains (losses) reclassified from AOCI to earnings	(53)	$ 41
Cash flow hedge (losses) expected to be reclassified into earnings within twelve months	(263)
Fair value hedges
Derivative Instruments, Gain (Loss) [Line Items]
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge	96
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	$ (96)

Equity Plans - Share Based Info

Equity Plans - Share Based Information and Restricted Stock Awards (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	2 Months Ended	10 Months Ended	12 Months Ended
	Oct. 31, 2021	Sep. 01, 2022	Sep. 01, 2022	Sep. 02, 2021	Sep. 03, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for future awards (in shares)		90	90
Tranche 1 - Initial vesting after one year
Restricted Stock and Restricted Stock Units ("Restricted Stock Awards")
Annual vesting rights, percentage		25%
Tranche 2 - Quarterly vesting for remaining three years
Restricted Stock and Restricted Stock Units ("Restricted Stock Awards")
Annual vesting rights, percentage		6.25%
Restricted stock awards
Restricted Stock Awards Roll Forward (Shares)
Number of Shares - Outstanding (in shares)	20		20
Number of Shares - Granted (in shares)			13	11	8
Number of Shares - Restrictions lapsed (in shares)			(7)
Number of Shares - Canceled (in shares)			(3)
Number of Shares - Outstanding (in shares)		23	23	20
Restricted Stock Awards Roll Forward (Weighted Average Grant Date Fair Value)
Weighted Average Grant Date Fair Value Per Share - Outstanding (in dollars per share)	$ 49.39		$ 49.39
Weighted Average Grant Date Fair Value Per Share - Granted (in dollars per share)			70.81	$ 53.58	$ 46.44
Weighted Average Grant Date Fair Value Per Share - Restrictions lapsed (in dollars per share)			47.36
Weighted Average Grant Date Fair Value Per Share - Canceled (in dollars per share)			57
Weighted Average Grant Date Fair Value Per Share - Outstanding (in dollars per share)		$ 60.93	$ 60.93	$ 49.39
Aggregate vesting-date fair value of shares vested			$ 498	$ 385	$ 294
Performance and Market-based Restricted Stock Awards
Restricted Stock and Restricted Stock Units ("Restricted Stock Awards")
Restricted award vesting period			3 years
Performance and Market-based Restricted Stock Awards \| Minimum
Restricted Stock and Restricted Stock Units ("Restricted Stock Awards")
Restricted award achievement potential, percentage			0%
Performance and Market-based Restricted Stock Awards \| Maximum
Restricted Stock and Restricted Stock Units ("Restricted Stock Awards")
Restricted award achievement potential, percentage			200%
Service-based Restricted Stock Awards
Restricted Stock Awards Roll Forward (Shares)
Number of Shares - Outstanding (in shares)		20	20
Service-based Restricted Stock Awards \| Minimum
Restricted Stock and Restricted Stock Units ("Restricted Stock Awards")
Annual vesting rights, percentage	25%
Service-based Restricted Stock Awards \| Maximum
Restricted Stock and Restricted Stock Units ("Restricted Stock Awards")
Annual vesting rights, percentage	33%
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for future awards (in shares)		18	18
Restricted Stock Awards Roll Forward (Weighted Average Grant Date Fair Value)
Weighted Average Grant Date Fair Value Per Share - Granted (in dollars per share)			$ 18.87	$ 20.71	$ 14.24

Equity Plans - ESPP and Stock O

Equity Plans - ESPP and Stock Options (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Sep. 01, 2022	Sep. 02, 2021	Sep. 03, 2020	Jul. 31, 2021
Employee Stock Purchase Plan
Employee Stock Purchase Plan ("ESPP")
ESPP maximum payroll deduction percentage (in hundredths)	15%			10%
ESPP percentage purchase price of common stock (in hundredths)	85%
Period from grant date until stock options expire or ESPP program period (in years or months)	6 months
ESPP shares purchased (in shares)	4	3	3
ESPP value of shares purchased	$ 215	$ 140	$ 118
ESPP Fair Value Assumptions and Methodology
Fair Value Assumptions, Method Used	Black-Scholes
Weighted-average grant-date fair value per share	$ 18.87	$ 20.71	$ 14.24
Average expected life in years	6 months	6 months	6 months
Weighted-average expected volatility (based on implied volatility)	43%	41%	45%
Weighted-average risk-free interest rate	2%	0.10%	0.80%
Expected dividend yield	0.60%	0.30%	0%
Employee Stock Option
Employee Stock Purchase Plan ("ESPP")
Period from grant date until stock options expire or ESPP program period (in years or months)	8 years
Stock Option Disclosures
Number of options outstanding (in shares)	3
Number of shares exercised (in shares)	1
Total intrinsic value for option exercised	$ 54	$ 143	$ 130

Equity Plans - Stock-based comp

Equity Plans - Stock-based compensation expense (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 01, 2022	Sep. 02, 2021	Sep. 03, 2020
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 496	$ 395	$ 328
Equity Plans, Additional Disclosures
Tax benefit from compensation expense	77	83	72
Total unrecognized compensation costs related to non-vested awards expected to be recognized	$ 1,020
Weighted average period that unrecognized compensation costs is expected to be recognized (in years)	1 year 3 months 18 days
Restricted stock awards
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 429	333	272
Employee Stock Purchase Plan
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	66	52	39
Employee Stock Option
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	1	10	17
Equity plans
Equity Plans, Additional Disclosures
Expense capitalized and remained in inventory	48	30
Cost of goods sold
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	193	186	139
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	175	110	86
Selling, general, and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	133	99	103
Restructure
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ (5)	$ 0	$ 0

Employee Benefit Plans - (Detai

Employee Benefit Plans - (Details) - USD ($) $ in Millions	12 Months Ended
Employee Benefit Plans - (Details) - USD ($) $ in Millions	Sep. 01, 2022	Sep. 02, 2021	Sep. 03, 2020
Employee Savings Plan for U.S. Employees
Maximum annual contributions per employee (in hundredths)	75%
Employer matching contribution, percent of employees' eligible earnings (in hundredths)	5%
Defined contribution plan contribution expense	$ 66	$ 77	$ 66
Retirement Plans
Projected pension benefit obligation	186	222
Pension plan assets	$ 221	$ 256

Revenue (Details)

Revenue (Details) - USD ($) $ in Millions	12 Months Ended
Revenue (Details) - USD ($) $ in Millions	Sep. 01, 2022	Sep. 02, 2021	Sep. 03, 2020
Disaggregation of Revenue [Line Items]
Revenue	$ 30,758	$ 27,705	$ 21,435
Estimated consideration payable to customers for pricing adjustments and returns	1,260	846
DRAM
Disaggregation of Revenue [Line Items]
Revenue	22,386	20,039	14,510
NAND
Disaggregation of Revenue [Line Items]
Revenue	7,811	7,007	6,131
Other (primarily 3D XPoint memory and NOR)
Disaggregation of Revenue [Line Items]
Revenue	$ 561	$ 659	$ 794

Restructure and Asset Impairm_3

Restructure and Asset Impairments (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 01, 2022	Sep. 02, 2021	Sep. 03, 2020
Restructuring and Related Activities [Abstract]
Restructure and asset impairments	$ 48	$ 488	$ 60

Other Operating (Income) Expe_3

Other Operating (Income) Expense, Net (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 01, 2022	Sep. 02, 2021	Sep. 03, 2020
Other Income and Expenses [Abstract]
Patent license charges	$ 0	$ 128	$ 0
(Gain) loss on disposition of property, plant, and equipment	(41)	(24)	(3)
Other	7	(9)	11
Other operating (income) expense, net	$ (34)	$ 95	$ 8

Other Non-Operating Income (E_3

Other Non-Operating Income (Expense), Net (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 01, 2022	Sep. 02, 2021	Sep. 03, 2020
Other Nonoperating Income (Expense) [Abstract]
Gain (loss) on investments	$ 26	$ 82	$ 22
Gain (loss) on debt prepayments, repurchases, and conversions	(83)	(1)	40
Other	19	0	(2)
Other non-operating income (expense), net	$ (38)	$ 81	$ 60

Income Taxes - Income (loss) be

Income Taxes - Income (loss) before Taxes and Other Items (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 01, 2022	Sep. 02, 2021	Sep. 03, 2020
Income (loss) before income taxes, net income (loss) attributable to noncontrolling interests, and equity in net income (loss) of equity method investees
U.S.	$ 112	$ (211)	$ 308
Foreign	9,459	6,429	2,675
Income (loss) before income taxes, net income (loss) attributable to noncontrolling interests, and equity in net income (loss) of equity method investees	9,571	6,218	2,983
Current
U.S. federal	(65)	(42)	(20)
State	(1)	(1)	(2)
Foreign	(528)	(370)	(148)
Total income tax (provision) benefit - current	(594)	(413)	(170)
Deferred
U.S. federal	(166)	(9)	39
State	(225)	28	23
Foreign	97	0	(172)
Total income tax (provision) benefit - deferred	(294)	19	(110)
Income tax (provision) benefit	$ (888)	$ (394)	$ (280)

Income Taxes - Effective Income

Income Taxes - Effective Income Tax Rate Reconciliation (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 01, 2022	Sep. 02, 2021	Sep. 03, 2020
Effective Income Tax Rate Reconciliation, Amount
U.S. federal income tax (provision) benefit at statutory rate	$ (2,010)	$ (1,306)	$ (626)
U.S. tax on foreign operations	(322)	(226)	(14)
Change in valuation allowance	(241)	54	(20)
Change in unrecognized tax benefits	(67)	(238)	(33)
Foreign tax rate differential	1,601	951	253
Research and development tax credits	66	123	62
Foreign derived intangible income deduction	41	18	67
State taxes, net of federal benefit	0	59	23
Debt premium deductions	0	130	0
Other	44	41	8
Income tax (provision) benefit	$ (888)	$ (394)	$ (280)
Effective Income Tax Rate Reconciliation, Percent
U.S. federal statutory rate (percent)	21%	21%	21%
U.S. tax on foreign operations (percent)	3.40%	3.60%	0.50%
Change in valuation allowance (percent)	2.50%	(0.90%)	0.70%
Unrecognized tax benefits (percent)	0.70%	3.80%	1.10%
Foreign tax rate differential (percent)	(16.70%)	(15.30%)	(8.50%)
Research and development tax credits (percent)	(0.70%)	(2.00%)	(2.10%)
Foreign derived intangible income (percent)	(0.40%)	(0.30%)	(2.20%)
State taxes, net of federal benefit (percent)	0%	(0.90%)	(0.80%)
Debt premium deductions (percent)	0%	(2.10%)	0%
Other (percent)	(0.50%)	(0.60%)	(0.30%)
Effective tax rate (percent)	9.30%	6.30%	9.40%

Income Taxes - Tax Holiday and

Income Taxes - Tax Holiday and Other (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Sep. 01, 2022	Sep. 02, 2021	Sep. 03, 2020
Income Tax Disclosure [Abstract]
Tax benefit from incentive arrangements	$ 1,120	$ 758	$ 215
Tax benefit per diluted share from incentive arrangements	$ 1	$ 0.66	$ 0.19
Undistributed earnings of foreign subsidiaries deemed indefinitely reinvested	$ 4,380

Income Taxes - Deferred Tax Ass

Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Millions	Sep. 01, 2022	Sep. 02, 2021
Deferred tax assets
Net operating loss and tax credit carryforwards	$ 796	$ 783
Accrued salaries, wages, and benefits	157	206
Operating lease liabilities	138	109
Inventories	77	0
Property, plant, and equipment	44	37
Other	142	115
Gross deferred tax assets	1,354	1,250
Less valuation allowance	(471)	(233)
Deferred tax assets, net of valuation allowance	883	1,017
Deferred tax liabilities
Right-of-use assets	(126)	(90)
Product and process technology	0	(12)
Other	(68)	(143)
Deferred tax liabilities	(194)	(245)
Net deferred tax assets	689	772
Reported as
Deferred tax assets	702	782
Deferred tax liabilities (included in other noncurrent liabilities)	$ (13)	$ (10)

Income Taxes - Operating Loss C

Income Taxes - Operating Loss Carryforwards (Details) $ in Millions	Sep. 01, 2022 USD ($)
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	$ 2,392
2023 - 2027
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	474
2028 - 2032
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	611
2033 - 2037
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	249
2038 - 2042
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	197
Indefinite
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	861
State
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	873
State \| 2023 - 2027
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	44
State \| 2028 - 2032
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	377
State \| 2033 - 2037
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	249
State \| 2038 - 2042
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	197
State \| Indefinite
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	6
Foreign \| Japan
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	652
Foreign \| Japan \| 2023 - 2027
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	418
Foreign \| Japan \| 2028 - 2032
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	234
Foreign \| Japan \| 2033 - 2037
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	0
Foreign \| Japan \| 2038 - 2042
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	0
Foreign \| Japan \| Indefinite
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	0
Foreign \| Malaysia
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	851
Foreign \| Malaysia \| 2023 - 2027
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	0
Foreign \| Malaysia \| 2028 - 2032
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	0
Foreign \| Malaysia \| 2033 - 2037
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	0
Foreign \| Malaysia \| 2038 - 2042
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	0
Foreign \| Malaysia \| Indefinite
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	851
Foreign \| Other
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	16
Foreign \| Other \| 2023 - 2027
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	12
Foreign \| Other \| 2028 - 2032
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	0
Foreign \| Other \| 2033 - 2037
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	0
Foreign \| Other \| 2038 - 2042
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	0
Foreign \| Other \| Indefinite
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	$ 4

Income Taxes - Tax Credit Carry

Income Taxes - Tax Credit Carryforwards (Details) $ in Millions	Sep. 01, 2022 USD ($)
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	$ 675
2023 - 2027
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	46
2028 - 2032
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	103
2033 - 2037
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	128
2038 - 2042
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	283
Indefinite
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	115
U.S. Federal
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	278
U.S. Federal \| 2023 - 2027
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	0
U.S. Federal \| 2028 - 2032
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	0
U.S. Federal \| 2033 - 2037
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	0
U.S. Federal \| 2038 - 2042
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	278
U.S. Federal \| Indefinite
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	0
State
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	397
State \| 2023 - 2027
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	46
State \| 2028 - 2032
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	103
State \| 2033 - 2037
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	128
State \| 2038 - 2042
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	5
State \| Indefinite
Tax Credit Carryforward [Line Items]
Tax credit carryforwards	$ 115

Income Taxes - Unrecognized Tax

Income Taxes - Unrecognized Tax Benefits (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 01, 2022	Sep. 02, 2021	Sep. 03, 2020
Unrecognized Tax Benefits Roll Forward
Beginning unrecognized tax benefits	$ 660	$ 411	$ 383
Increases related to tax positions from prior years	14	2	14
Increases related to tax positions taken in current year	80	260	27
Decreases related to tax positions from prior years	(23)	(13)	(13)
Ending unrecognized tax benefits	731	660	411
Unrecognized Tax Benefits that Would Impact Effective Tax Rate	564
Income Tax Contingency [Line Items]
Deferred State and Local Income Tax Expense (Benefit)	$ 225	$ (28)	$ (23)
Internal Revenue Service (IRS)
Income Tax Contingency [Line Items]
Income Tax Examination, Year under Examination	2018 2019
U.S. Federal \| Earliest Tax Year
Income Tax Contingency [Line Items]
Open Tax Year	2018
U.S. Federal \| Latest Tax Year
Income Tax Contingency [Line Items]
Open Tax Year	2022
State \| Earliest Tax Year
Income Tax Contingency [Line Items]
Open Tax Year	2018
State \| Latest Tax Year
Income Tax Contingency [Line Items]
Open Tax Year	2022
Foreign \| Earliest Tax Year
Income Tax Contingency [Line Items]
Open Tax Year	2016
Foreign \| Latest Tax Year
Income Tax Contingency [Line Items]
Open Tax Year	2022
IDAHO
Income Tax Contingency [Line Items]
Deferred State and Local Income Tax Expense (Benefit)	$ 189
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	$ 189

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Sep. 01, 2022	Sep. 02, 2021	Sep. 03, 2020
Earnings Per Share Reconciliation
Net income attributable to Micron – Basic	$ 8,687	$ 5,861	$ 2,687
Assumed conversion of debt	0	0	(4)
Net income attributable to Micron – Diluted	$ 8,687	$ 5,861	$ 2,683
Weighted Average Number of Shares Outstanding Reconciliation
Weighted-average common shares outstanding – Basic	1,112	1,120	1,110
Dilutive effect of equity plans and convertible notes	10	21	21
Weighted-average common shares outstanding – Diluted	1,122	1,141	1,131
Basic (in dollars per share)	$ 7.81	$ 5.23	$ 2.42
Diluted (in dollars per share)	$ 7.75	$ 5.14	$ 2.37
Antidilutive potential common shares that could dilute basic earnings per share in the future (in shares)	5	2	5

Segment and Other Information_2

Segment and Other Information (Details) $ in Millions	3 Months Ended	12 Months Ended
Segment and Other Information (Details) $ in Millions	Mar. 04, 2021 USD ($)	Sep. 01, 2022 USD ($) segment	Sep. 02, 2021 USD ($)	Sep. 03, 2020 USD ($)
Reportable Segments
Number of reportable segments \| segment		4
Additional Segment Information
Goodwill		$ 1,228	$ 1,228
Net sales
Revenue		30,758	27,705	$ 21,435
Operating income (loss)
Stock-based compensation		(496)	(395)	(328)
Inventory accounting policy change to FIFO		(16,860)	(17,282)	(14,883)
Restructure and asset impairments		48	488	60
Patent license charges		0	128	0
Operating income (loss)		9,702	6,283	3,003
Depreciation and amortization
Depreciation and amortization expense by segment		7,116	6,214	5,650
3D XPoint
Operating income (loss)
3D XPoint inventory write-down			(49)
Change in Accounting Principle, Inventory Method
Operating income (loss)
Inventory accounting policy change to FIFO	$ (133)
Operating Segments
Operating income (loss)
Operating income (loss)		10,281	7,667	3,419
Unallocated
Operating income (loss)
Stock-based compensation		(501)	(395)	(328)
Change in inventory cost absorption		0	(160)	0
Restructure and asset impairments		48	488	60
Patent license charges		0	128	0
Other		(30)	(31)	(28)
Operating income (loss)		(579)	(1,384)	(416)
Depreciation and amortization
Depreciation and amortization expense by segment		20	27	28
Unallocated \| 3D XPoint
Operating income (loss)
3D XPoint inventory write-down		0	(49)	0
Unallocated \| Change in Accounting Principle, Inventory Method
Operating income (loss)
Inventory accounting policy change to FIFO		0	(133)	0
CNBU
Additional Segment Information
Goodwill		832	832
Net sales
Revenue		13,693	12,280	9,184
CNBU \| Operating Segments
Operating income (loss)
Operating income (loss)		5,844	4,295	2,010
Depreciation and amortization
Depreciation and amortization expense by segment		2,766	2,497	2,318
MBU
Additional Segment Information
Goodwill		198	198
Net sales
Revenue		7,260	7,203	5,702
MBU \| Operating Segments
Operating income (loss)
Operating income (loss)		2,160	2,173	1,074
Depreciation and amortization
Depreciation and amortization expense by segment		1,725	1,553	1,436
EBU
Additional Segment Information
Goodwill		97	97
Net sales
Revenue		5,235	4,209	2,759
EBU \| Operating Segments
Operating income (loss)
Operating income (loss)		1,752	1,006	301
Depreciation and amortization
Depreciation and amortization expense by segment		1,280	1,028	741
SBU
Additional Segment Information
Goodwill		101	101
Net sales
Revenue		4,553	3,973	3,765
SBU \| Operating Segments
Operating income (loss)
Operating income (loss)		513	173	36
Depreciation and amortization
Depreciation and amortization expense by segment		1,323	1,101	1,115
All Other
Net sales
Revenue		17	40	25
All Other \| Operating Segments
Operating income (loss)
Operating income (loss)		12	20	(2)
Depreciation and amortization
Depreciation and amortization expense by segment		$ 2	$ 8	$ 12

Certain Concentrations (Details

Certain Concentrations (Details) - Revenue from Contract with Customer	12 Months Ended
	Sep. 01, 2022	Sep. 02, 2021	Sep. 03, 2020
Product Concentration Risk \| Mobile
Concentration Risk [Line Items]
Concentration Risk, Percentage	25%	25%	25%
Product Concentration Risk \| Client and graphics
Concentration Risk [Line Items]
Concentration Risk, Percentage	20%	20%	20%
Product Concentration Risk \| Enterprise and cloud server
Concentration Risk [Line Items]
Concentration Risk, Percentage	20%	20%	20%
Product Concentration Risk \| SSDs and other storage
Concentration Risk [Line Items]
Concentration Risk, Percentage	15%	15%	20%
Product Concentration Risk \| Automotive, industrial, and consumer
Concentration Risk [Line Items]
Concentration Risk, Percentage	15%	15%	15%
Customer Concentration Risk \| Kingston
Concentration Risk [Line Items]
Concentration Risk, Percentage	12%		11%
Customer Concentration Risk \| WPG Holdings Limited
Concentration Risk [Line Items]
Concentration Risk, Percentage	11%	13%

Geographic Information (Details

Geographic Information (Details) - USD ($) $ in Millions	12 Months Ended
Geographic Information (Details) - USD ($) $ in Millions	Sep. 01, 2022	Sep. 02, 2021		Sep. 03, 2020
Revenue by Geographic Location of Customers' Headquarters
Revenue	$ 30,758	$ 27,705		$ 21,435
Long-Lived Assets by Geographic Location
Long-lived assets	39,227	34,663
United States
Revenue by Geographic Location of Customers' Headquarters
Revenue	16,026	12,155		10,381
Long-Lived Assets by Geographic Location
Long-lived assets	5,155	5,205	[1]
United States \| Lehi, Utah Facility
Long-Lived Assets by Geographic Location
Long-lived assets		899
Taiwan
Revenue by Geographic Location of Customers' Headquarters
Revenue	6,185	6,606		3,657
Long-Lived Assets by Geographic Location
Long-lived assets	13,143	11,457
Mainland China (excluding Hong Kong)
Revenue by Geographic Location of Customers' Headquarters
Revenue	3,311	2,456		2,337
Long-Lived Assets by Geographic Location
Long-lived assets	440	436
Japan
Revenue by Geographic Location of Customers' Headquarters
Revenue	1,696	1,652		1,387
Long-Lived Assets by Geographic Location
Long-lived assets	7,113	7,222
Hong Kong
Revenue by Geographic Location of Customers' Headquarters
Revenue	1,665	2,582		1,792
Other Asia Pacific
Revenue by Geographic Location of Customers' Headquarters
Revenue	1,223	1,420		1,157
Other
Revenue by Geographic Location of Customers' Headquarters
Revenue	652	834		$ 724
Long-Lived Assets by Geographic Location
Long-lived assets	337	175
Singapore
Long-Lived Assets by Geographic Location
Long-lived assets	12,045	9,411
Malaysia
Long-Lived Assets by Geographic Location
Long-lived assets	$ 994	$ 757

[1]Included $899 million (net of impairment) as of September 2, 2021 of property, plant, and equipment for our Lehi facility that was classified as held for sale and presented in other current assets.

Schedule II Valuation and Qua_3

Schedule II Valuation and Qualifying Accounts (Details) - Deferred Tax Assets Valuation Allowance - USD ($) $ in Millions	12 Months Ended
	Sep. 01, 2022	Sep. 02, 2021	Sep. 03, 2020
Deferred Tax Asset Valuation Allowance Roll Forward
Balance at Beginning of Year	$ 233	$ 294	$ 277
Charged to Income Tax Provision	241		20
(Credited) to Income Tax Provision		(54)
Currency Translation and Charges to Other Accounts	(3)	(7)	(3)
Balance at End of Year	$ 471	$ 233	$ 294